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Summary
Neuronal activity is required for proper neural development, as well as for the main-
tenance of neural circuits, adaptation to changing environments, learning and memory
formation. Electrical activation of neurons induces transient increases in the intra-
cellular calcium (Ca2+) concentration, which can propagate to the nucleus thereby
linking synaptic stimulation to gene regulatory events. However, it is unclear if and
how different spatial-temporal patterns of activity give rise to distinct genomic res-
ponses. In this thesis I used optogenetic method to investigate activity dependent
regulation of signaling pathways and gene expression in cultured hippocampal neu-
rons. The goal was to investigate whether intrinsic activity could be mimicked in a
controllable way, and if yes, how this was achieved. Specifically, I used Channel-
rhodopsin (ChR2), a light-gated, cation-selective, small membrane channel isolated
from Chlamydomonas reidhardtii. ChR2 can be activated with blue light and functions
without any addition of cofactor when expressed in mammalian systems. I used trans-
fection and adeno-associated virus-mediated gene transfer to express ChR2 in cultured
hippocampal neurons, which afterwards could be stimulated and activated with blue
LED pulses to reliably induce action potential firing and Ca2+ transients. A double mu-
tant variant of ChR2, ChR2-ab, was made, characterized and its cellular functions were
studied. The results indicated that ChR2-ab inherited the properties from its previous
single mutant, being more sensitive, longer opening and bi-stable. Neurons expressing
ChR2-ab responded to light exposure with membrane depolarization, which ultimately
led to the expression of a previously characterized pool of activity-dependent genes.
ChR2-ab-mediated induction of these genes was L-type voltage-dependent Ca2+ chan-
nel dependent, as it was completely blocked with nifedifine. Similarly, treatment of
ChR2-ab-expressing neurons with NMDA receptor blockers MK-801 and APV inhib-
ited the light-evoked induction of atf3, ifi202b, inhba and serpinb2. When synaptic
activity was inhibited with Na+ channel blocker TTX to prevent action potential fir-
ing, ChR2-ab-mediated gene induction of atf3, inhba, npas4, nr4a1 and serpinb2 was
also restrained. Expression of CaMBP4, an inhibitor of nuclear Ca2+/CaM complex,
revealed that ChR2-ab-mediated gene induction dependent on nuclear Ca2+ signaling.
Interfering the function of CREB/CBP transcription complex with E1A protein dimin-
ished gene expression induced with ChR2-ab. Whole-cell patch-clamp and signaling
pathway analysis revealed that neurons expressing ChR2-ab had higher basal activity,
with more frequent mEPSC and higher level of pCREB and pERK. However, some
ChR2-ab-expressing cells died after light application on day in vitro 14. Pharmacolog-
ical analysis suggested that this was due to activation of extra-synaptic NMDA recep-
tors during ChR2-ab activation. In an alternative strategy to induce activity, ChR2 was
targeted to the membrane of endoplasmic reticulum using various targeting sequences
with the goal to directly trigger Ca2+ release from this internal Ca2+ store. Additionally,
transcription analysis with catFISH method revealed that a single nuclear Ca2+ transient
induced with Bicuculline treatment was capable and sufficient to initiate transcription
of arc gene.

Zusammenfassung
Die Neuronale Aktivität ist für eine ordnungsgemäße Nervenentwicklung, sowie für
die Erhaltung neuronaler Schaltkreise, für Adaptation auf sich ändernde Umgebun-
gen und für das Lernen als auch für die Bildung des Gedächtnisses erforderlich. Die
elektrische Aktivierung von Neuronen führt zu vorrübergehenden Erhöhungen der in-
trazellulären Kalziumkonzentration (Ca2+), die zum Zellkern weitergeleitet werden
kann, wodurch eine synaptische Stimulation mit der Genregulation verbunden wird.
Es ist jedoch unklar, ob und in welcher Art räumliche und zeitliche Aktivitätsmuster
zu unterschiedlichen genomischen Antworten führen. In dieser Arbeit habe ich opto-
genetische Methoden verwendet, um aktivitätsabhängige Regulierungen der Signal-
wege und der Genexpression in Zellkulturen von hippocampalen Neuronen zu unter-
suchen. Es war das Ziel herauszufinden, ob intrinsische Aktivität auf kontrollierbare
Weise nachgeahmt werden kann, und wenn dies möglich ist, wie dies erreicht werden
kann. Dafür verwendete ich Channelrhodopsin (ChR2), ein kleiner licht-gesteuerter,
Kationen-sensitiver Membrankanal, welcher aus Chlamydomonas reidhardtii isoliert
wurde. ChR2 kann mit blauem Licht angeregt werden und kann bei der Expression im
Säugertiersystem ohne Zugabe von Cofaktoren seine Funktion ausführen. Ich verwen-
dete Transfektionen und Adeno-assoziierten Virus-vermittelten Gentransfer, um ChR2
in kultivierten hippocampalen Zellen zu exprimieren. Später können diese mit blauem
LED-Licht angeregt werden, um zuverlässig Aktionspotentiale und Ca2+-Ströme zu
erzeugen. Zusätzlich habe ich eine Doppelmutante von ChR2, Chr2-ab hergestellt,
diese charakterisiert und ihre zellulären Funktionen untersucht. Die Ergebnisse zeigen,
dass ChR2-ab die Eigenschaften seiner Vorläuferversion beibehalten hat, darüber hin-
aus empfindlicher ist, zu einer längeren Öffnung des Kanals führt und bistabil ist. Be-
strahlt man nun Neuronen, die ChR2 expremieren, mit blauem Licht, so führt dies zur
Membrandepolarisierung der Nervenzelle, wodurch letztendlich die Expression von
bekannten aktivitätsabhängigen Genen induziert wird. Die ChR2-ab-vermittelte In-
duktion dieser Gene war abhängig von L-Typ spannungsabhängigen Kalziumkanälen,
da diese durch Verwendung von Nifedipine vollständig blockiert werden konnten. Zu-
dem führt die Behandlung mit NMDA-Rezeptor Blocker MK801 und APV in ChR2-
ab exprimierenden Neuronen zur Inhibierung der Licht-induzierten Expression von
atf3, ifi202b, inhba und serpinb2. Wenn synaptische Aktivität mit dem Natrium-
Kanal Blocker TTX inhibiert wurde, um zu verhindern, dass Aktionspotentiale aus-
gelöst wurden, wurde die ChR2-ab-vermittelte Induktion der Gene atf3, inhba, npas4,
nr4a1 und serpinb2 verringert. Die Expression von CaMBP4, einem Inhibitor des
nukleären Ca2+/Calmodulin-Komplexes, führte dazu, dass eine ChR2-ab-vermittelte
Geninduktion von kernständigem Ca2+ abhängig ist. Wenn man mit dem E1A Protein
in die Funktionsweise des CREB/CBP Transkriptionskomplexes eingreift, wird die
ChR2-ab-induzierte Genexpression zusätzlich verringert. "Whole-cell Patch-Clamp"
und eine Untersuchung der Signalwege haben gezeigt, dass Neuronen, die ChR2-ab
exprimieren, häufiger mEPSCs (mini excitatory postsynaptic currents) und eine höhere
Menge an pCREB und pERK aufweisen und somit eine höhere Basalaktivität haben.
Jedoch starben einige ChR2 exprimierende Zellen nach der Anwendung von Licht an
Tag in vitro 14. Pharmakologische Untersuchungen wiesen darauf hin, dass dies durch
die Aktivierung der extrasynaptischen NMDA Rezeptoren während der Aktivierung
von ChR2-ab verursacht wurde. In einem weiteren Ansatz zur Induktion der Aktiv-
ität wurde ChR2 durch Verwendung verschiedener Zielsequenzen an die Membran des
Endoplasmatischen Reticulums lokalisiert, mit der Zielsetzung eine Ca2+ -Freisetzung
unmittelbar aus diesen internen Ca2+-Speichern auszulösen. Zusätzlich wurde eine
Transkriptionsanalyse mit der catFISH Methode durchgeführt, in der gezeigt wurde,
dass ein einziger, durch Bicuculline Behandlung induzierter, kernständiger Ca2+ Strom
ausreicht, um die Transkription des Gens arc zu initiieren.
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Chapter 1
Introduction
1.1 Activity-dependent Gene Expression
Extrinsic activity input plays essential roles in the proper development of neural circuitry during
the early stage, in the adulthood to maintain normal function and to form long-lasting memories
and other adaptations [8, 108, 145]. In infancy and also in adult, the memories and adaptations
are ultimately mediated by experience-driven changes in connectivity of neural network [1]. These
changes are central to our everyday lives and are tragically disrupted in numerous neurological,
psychiatric, and neurodegenerative disorders [29]. Gene expression is believed to be the central
mediator for this connectivity change [137]. Neurons change their gene expression patterns accord-
ing to the inputs they have received [105, 157]. Many genes are known to be regulated by neural
activity and some of them are essential for the formation of the chemical and structural changes ac-
cording to the activity input. These gene products are believed to affect dendrite development, axon
branching, formation of synapses between axon and dendrite, and stabilizing the activity-dependent
refinement of the neural circuits [31, 40, 151, 155]. This is important for synaptic plasticity, which
is the capability for modification of the strength of neuronal connections [67]. And these kinds
of long-lasting changes in the strength of synaptic connections modified by gene transcription are
believed to be the cellular mechanism for memory formation [3, 131]. Several cellular signaling
pathways are activated according to the neural activity; these signaling pathways often affect the
transcription of neuronal genes [2]. Responding to synaptic activity, Ca2+ influx through NMDA
receptors or L-type VGCC activates Ca2+ dependent kinase CaMKII or CaMKKIV, which phos-
phorylate CREB at Ser 133. Phosphorylated CREB binds to its coactivator CBP/p300 and activates
the transcription of its downstream genes. The neural activity-dependent expression of genes is
also affected by epigenetic processes such as methylation of DNA or modification of histones [4].
Studies in nonhuman animals suggest that more stimulating environment could aid the treatment
and recovery of a diverse variety of brain related dysfunctions, including Alzheimer’s disease and
those connected to aging, whereas lack of stimulation might impair cognitive development [34, 66,
72, 146]. Brains in richer, more stimulating environments, have increased numbers of synapses, and
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the dendrite arbors upon which they reside are more complex [143]. With extra synapses there is
also increased synapse activity and so increased size and number of glial energy support cells. The
requirement of for activation of transcription for neuronal plasticity is best studied using long-term
potential (LTP). LTP is a long-lasting enhancement in signal transmission between two neurons
that results from stimulating them synchronously [33]. It is believed to be the major phenomena
underlying synaptic plasticity, the ability of chemical synapses to change their strength. Memories
are thought to be encoded by modification of synaptic strength, so LTP is widely accepted as the
major cellular mechanisms for learning and memory [20, 19].
1.1.1 Synaptic and Extrasynaptic NMDA Receptors
NMDA receptors are cation channels gated by neurotransmitter glutamate and are one of the major
Ca2+ permeable receptors in neurons [63, 65]. NMDA receptors are vital for normal brain func-
tions [1]. They are central to activity-dependent changes in synaptic strength and connectivity
Figure 1.1: Schematic illustration of opposing effects of synaptic and extrasynaptic NMDA receptors on cell
survival. Figure is obtained from [59].
which are thought to be underlying the formation of memory and learning [158]. During the devel-
opment, NMDA receptors switch in sub-type and change their location [35, 138]. There has been
a long-standing paradox about NMDA receptors being both neuron-protective and neuron-lethal
[58]. Growing evidence suggests that physiological level of synaptic NMDA receptors activation
can promote neuron survival and render them more resistant to deleterious insults [106, 157]. Pre-
vious data show that hippocampal neurons have two functionally distinct NMDA receptor signaling
pathways [59]. Synaptic complexes promote nuclear signaling to CREB, induce BDNF gene ex-
pression, and activate an anti-apoptotic pathway; extrasynaptic complexes antagonize nuclear sig-
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naling to CREB, block induction of BDNF expression, and are involved in mitochondrial dysfunc-
tion and cell death [139]. As illustrated in Figure 1.1, hypoactivity of synaptic NMDA receptors is
harmful to neurons. Enhancing synaptic NDMA receptor activity triggers multiple neuroprotective
pathways and this promotes neuronal survival. Low levels of activation of extrasynaptic NMDA
receptors have no effects on neuronal survival but increasing the level of extrasynaptic NDMA re-
ceptor activity activates cell death pathways and exacerbates certain neurodegenerative processes,
thus reducing neuronal survival [62]. For instance, the balance between synaptic and extrasynaptic
NMDA receptor signaling was reported to control the formation of of mutant huntington inclusions,
neurotoxicity and disease severity and progression in dodels of Huntington’s disease [102].
1.1.2 CREB
Activity dependent activation of the transcription factor CREB (cyclic-AMP response element
binding protein) is heavily implicated in synaptic plasticity, learning and survival [21, 88, 121].
Neural activity induces the phosphorylation of CREB and activates its gene transcription activity
[27]. CREB is one of the major transcription activators mediating Ca2+ induced gene expression
[4]. It was first isolated as a phosphor-protein binding the CRE (cyclic-AMP response element, 5′-
TGACGTCA-3′) on the mouse somatostatin gene [95]. Upon discovery, it attracted focus from all
fields, especially from neuroscience. Typical isoforms of CREB are αCREB, βCREB and ∆CREB
[84, 120]. It plays important role in information storage and mice deficient in α and β forms of
CREB have defective long term memory [22]. CREB is known to be generally constitutively ex-
pressed and activated via post-translational modifications such as phosphorylation. Phosphoryla-
tion of residue serine-133 is particularly important and regarded as a marker for CREB-mediated
transcription [47]. CREB phosphorylation on serine-133 can be mediated by a number of protein
kinases, including the multifunctional calcium/calmodulin (Ca2+/CaM) dependent protein kinases
(CaMK) II and IV [39]. Both CaMK II and IV have an N-terminal catalytic domain and a central
Ca2+/CaM binding regulatory domain. Activation of enzymes occurs when Ca2+/CaM complex
binds and displaces the auto-inhibitory domain. In addition to phosphorylation at serine 133 site,
CREB can also be phosphorylated at serine 142 by CaMKII, which exhibits inhibitory effect on
CREB mediated gene expression [130]. As CaMKIV is expressed dominantly in nucleus and effi-
cient in activating CREB, it appears to be a prime candidate for the activation of CREB mediated
gene expression by nuclear Ca2+ signals [90].
However, CREB phosphorylation on serine 133 does not necessarily indicate that CREB-dependent
gene expression is induced [28]. It still needs recruitment of the co-activator CBP (CREB bind-
ing protein). CBP and its close relative p300 are vital components of the cellular machinery that
regulate gene expression [77]. CBP binds specifically to phosphorylated CREB and can connect
sequence-specific transcriptional activators to components of the basal transcription machinery and
may disrupt repressive chromatin structures through its intrinsic or associated histone acetyltrans-
ferase activity [78]. Downstream of CREB, there are quite a large number of target genes. Among
those, c-fos is one of the first and most extensively examined genes. c-fos has both CRE and SRE
(serum response element) and its expression is tightly regulated by neuronal activity [37].
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1.1.3 Immediate Early Gene: Arc
Neural activity-dependent gene transcription occurs over various time periods, ranging from min-
utes to days. One of the rapidest gene induction is observed in the transcriptional activation of a
group of genes called the "immediate early genes" (IEG) [79]. These genes are activated rapidly
and transiently in response to a wide variety of cellular stimuli without any other protein synthe-
sis. They represent a standing response mechanism that is activated at the transcription level in
the first round of response to stimuli. Thus IEGs are distinct from "late response" genes, which
can only be activated later, following the synthesis of early response gene products [103]. About
40 cellular IEGs have been identified so far. The earliest known and best characterized include
c-fos, c-myc and c-jun, genes that were found to be homologous to retroviral oncogenes [96]. In
their role as "gateways to genomic response", many IEG products are naturally transcription fac-
tors or other DNA-binding proteins. However, other important classes of IEG products include
secreted proteins, cytoskeletal proteins, and receptor subunits. One of these genes, Arc, encoding
the activity-regulated cytoskeleton-associated protein, is transcribed in the rat brain as rapidly as 5
min after the animal has moved from its familiar home cage to a novel environment [142].
Arc is specially required for long-term memory formation and affects all of these forms of
synaptic plasticity [123]. Arc is found only in vertebrates and is highly conserved [85]. Gluta-
matergic neurons in the brain express Arc in response to an increase in synaptic activity in a range
of behavioral stimuli. Localization and stability of the transcript and protein are highly regulated.
Arc protein is not found in presynaptic terminals or axons but is highly expressed in dendrites, the
postsynaptic density and the nucleus [127]. Via regulating AMPA receptor endocytosis and surface
inserting, Arc modulates synaptic transmission and plays a role in the homeostatic regulation of
synaptic strength [30, 115].
Using a very sensitive method, cellular compartment analysis of temporal activity by fluorescent
in-situ hybridization (catFISH), J.F. Guzowski et al. detected Arc mRNA in discrete intranuclear
foci within minutes of neuronal activation and subsequent disappearance from the nucleus and
accumulation in cytoplasm by 30 minutes [53]. Given the critical role in neuronal plasticity and
memory formation and its fast transcription start, Arc was chosen as a model gene to study the
minimal activity requirement for gene transcription initiation in this work.
1.2 Ca2+ in Neurons
In neurons, calcium ions (Ca2+) control gene transcription induced by synaptic activity [44]. Ca2+
signals are key mediators of numerous adaptive changes in the nervous system that are initiated by
electrical activity. It is the principal second messenger which controls diverse cellular mechanisms
such as development, morphogenesis, learning and memory and other adaptations to environments
[18]. To control multiple processes using a signal second messenger, neurons exploit the spatial and
temporal differences of calcium signals associated with electrical activity. The states and histories
of neuronal activity are represented by a calcium code that comprises the site of Ca2+ entry, and
the amplitude, duration and spatial properties of signal-evoked Ca2+ transients [17]. The site of
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Ca2+ entry can determine the biological outcome of calcium signaling, as shown by site-specific
differences in the regulation of CREB-mediated transcription [57].
1.2.1 Ca2+ Entry
As the best well-known second message, Ca2+ plays extraordinarily important and versatile roles
in every type of cell. It is responsible for coupling many of external events or stimuli to the cell’s
responses [32]. Ca2+ plays a central role to in the nervous system, as well as mediating other im-
portant processes such as activation of the immune system [25]. Its functional range includes such
varied processes as secretion, contraction, metabolism, gene expression, apoptosis and learning and
memory. During development, it is responsible for controlling numerous biological processes [18],
including fertilization, proliferation, cell type specialization. Regular Ca2+ spikes sweep through
the egg which will initiate internal Ca2+ induced Ca2+ release during fertilization. This regular pat-
tern of Ca2+ spiking stimulates CAMKII, which then acts through CDC25 to dephosphorylate the
enzyme cyclin-dependent kinase 1 (CDK1), resulting in cyclin B activation and the completion of
meiosis. During the phase of cell proliferation, Ca2+ oscillates as the cell cycle does. Spontaneous
Ca2+ transients trigger specific events such as nuclear envelope breakdown [76] and cell cleavage
[26]. In lymphocytes, the signaling from antigen binding to the T-cell receptor will be transduced
to phospholipase C, gamma 1 (PLCγ1), which produces both DAG and IP3 for a prolonged Ca2+
elevation to activate proliferation [15].
In the central nervous system, Ca2+ plays vital roles in connecting neurons. Synaptic transmitter
release from the presynaptic neuron activates the receptors on the postsynaptic membrane, opening
of Ca2+ channels couples this chemical event to electrical changes of the cell [45]. Activity-induced
Ca2+ influx into mature neurons affects synaptic function by acting both at the synapse and within
the nucleus [11]. Long term potentiation (LTP), the proposed molecular model for learning and
memory, will be impaired if Ca2+ influx from outside is blocked. Ca2+ signal in neurons has very
strict spatial and temporal regulation to achieve this versatility [42]. In the case of synaptic spe-
cific stimulation, Ca2+ responses will be restricted only to those spines [86]. Individual spines can
undergo input-specific, Ca2+-dependent synaptic modifications during the process of learning and
memory [160]. Between cell membrane, there is a ten thousand folds Ca2+ concentration differ-
ence: 100 nM in the cytoplasm and 1 mM outside. Ca2+ influx coming from outside in some cases is
restricted to synapses to achieve the synapse-specific long term potentiation, and sometimes trans-
duced to the nucleus to induce gene expression, global structural changes. Different apartments
within neuron have different levels of Ca2+ and undergo diverse functions. For example, Ca2+ con-
centration in the endoplasmic reticulum (ER) is 100 µM [50], which is much higher than that in
the cytoplasm and therefore ER serves as a good internal Ca2+ stores [141].
1.2.2 Ca2+ Buffering and Uptaking
Signal Ca2+ is derived either from the external medium or from internal stores. Entry of Ca2+ from
the outside medium is driven by the presence of a large electrochemical gradient across the plasma
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membrane. There are many different plasma-membrane receptor channels controlling Ca2+ entry
from the external medium. Receptor-operated N-methyl-D-aspartate (NMDA) and voltage-operated
Ca2+ channels are the two major sites for Ca2+ entry into hippocampal neurons. Differently located
receptors or channels can induce various responses. It is well demonstrated that NMDA receptors
sitting in the synaptic cleft mediate cell survival signal, while extrasynaptic NMDA receptors lead
to neuronal death [139]. L-type Ca2+ channels are voltage gated and mainly sit on the cell body and
proximal dendrites, which is an ideally position for providing Ca2+ signal inducing gene expression.
As mentioned above, Ca2+ concentration in the ER is much higher than that in the cytoplasm;
this makes ER a perfect internal Ca2+ storage. And there are different Ca2+ channels on the ER
membrane regulating the Ca2+ release from it, within which inositol 1, 4, 5-triphosphate recep-
tors (IP3R) and the ryanodine receptors (RyR) are the major mediators for internal Ca
2+ release
[14, 16, 24, 159]. Immunostaining of cerebellar Purkinje cells revealed that the receptor is ex-
pressed in the ER, nuclear envelope, and portions of the Golgi complex, but not mitochondria or
plasma membranes [116]. The primary determinants for IP3R are IP3 and Ca2+. IP3 is generated
by hydrolysis of phosphatidylinositol-4, 5-bisphosphate by a family of phospholipase C enzymes
(PLCβ, PLCγ et al.) [148]. The binding of IP3 increases the sensitivity of the receptor to Ca2+. A
special property of IP3R is that it is also Ca2+ sensitive, meaning Ca2+ induced Ca2+ release (CICR)
from these channels, which contributes to the rapid rise of Ca2+ levels and the development of
regenerative Ca2+ waves [41].
In fact, Ca2+ is not free to diffuse in the cell, but that there are a lot of Ca2+ binding proteins
buffering the movement of Ca2+. Most of the Ca2+ that enters the cytoplasm is rapidly bound to var-
ious cytosolic buffers such as parvalbumin, calbindin and calretinin. Cytosolic buffers are involved
in shaping both the amplitude and duration of Ca2+ signals. This is particularly important in neu-
rons for that Ca2+ signals are largely confined to synapses. There is another family of Ca2+ buffers,
termed as Ca2+ sensors, which respond to an increase in Ca2+ by activating diverse processes. The
classical sensors are troponin C (TnC) and calmodulin (CaM) [43]; they have four EF hands that
bind Ca2+ and undergo conformational changes to activate various downstream effectors. In the
case of CaM, Ca2+/CaM complexes activate the responsive downstream kinases, such as CaMKII
and CaMKIV.
On the other hand, the cytoplasmic Ca2+ concentration can not always be so high after an in-
crease. Once Ca2+ has carried out its signaling functions, it is removed from the cytoplasm by var-
ious pumps and exchangers. Ca2+-ATPase pumps and Na+/Ca2+ exchangers on the cell membrane
extrude Ca2+ to the outside medium. And sarco-endoplasmic reticulum Ca2+-ATPase (SERCA)
pumps will return Ca2+ to the internal stores. Another important component of Ca2+ uptake mech-
anism is mitochondria. Mitochondria create an electrochemical gradient by excluding protons to
synthesis ATP and also for Ca2+ uptake through a uniporter which has low sensitivity to Ca2+.
For neurons, this elevated Ca2+ clearance is especially important as that neurons often respond
to changes in stimulus intensity by varying the frequency of Ca2+ waves. Without this Ca2+ uptake,
a steady level of the same average Ca2+ concentration will be maintained and this is much less
efficient in signalling transduction, such as initiating gene expression [81].
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1.2.3 Nuclear Ca2+
Although remarkable progress has been made in revealing the signaling mechanism that regulates
activity-dependent gene transcription, many questions remain to be answered. One is how synap-
tic signals are sent to the nucleus. Neural activity is received at the synapses, however, the signal
is transduced into a nucleus that is located hundreds of microns distant from the synapses. One
hypothesis is that the signal is transduced only as a membrane depolarization, which is, the neural
activity itself. However, there are many different transcription factors that are activated by activity-
dependent Ca2+ influx. How cells interpret these Ca2+ signals and convert them into specific tran-
scriptional responses remains unclear. One way to circumvent that confusion inside the nucleus
would be to send a specific signal to the nucleus only when synapses are activated at a specific
input sufficient to modify their gene expression. Elevation of nuclear calcium is required for sus-
tained gene expression induced by neuronal activity [11]. The sub-cellular pattern of Ca2+ signals
is an important component of how this second messenger regulates cell function [55]. In neurons,
Ca2+ controls gene transcription induced by synaptic activity. There are two strategies to couple
external stimuli to transcription. The first one is that, close to the site of Ca2+ entry, it activates
cytoplasmic signalling molecules. These then transduce the signal in a Ca2+ independently manner
to the nucleus. Among those, extra-cellular signal regulated kinase (ERK) signalling cascade is
the prime target of these local Ca2+ transients. Ca2+ influx through NMDA receptors activate ERK
pathway and the latter then regulates several transcription factors [37]. Secondly, Ca2+ can directly
enter the nucleus and function there to activate target gene expression [61]. However, in this case, it
is not the same Ca2+ at the entering site that goes into nucleus. But that this process is achieved by
the CICR from internal stores or the coinciding with back-propagating dendritic action potentials.
Nuclear Ca2+ stimulates CREB-mediated transcription and, through inducing the activity of the
transcriptional co-activator CBP, may modulate the expression of numerous genes including neu-
rotransmitter receptors and scaffolding proteins [9]. Blockade of nuclear Ca2+ increase by microin-
jection of a non-diffusible Ca2+ chelator abolished CRE mediated gene expression, demonstrating
that nuclear Ca2+ is essential for neuronal gene expression.
1.2.4 Imaging Ca2+ Signals
Activity-induced Ca2+ signals propagate from the starting site to nucleus to initiate gene responses.
Therefore, visualization of cytosolic and nuclear Ca2+ is of great relevance in understanding the cel-
lular behavior upon different stimuli. For the past decade progressive advances have been made in
the design Ca2+ sensors. Basically, there are two major groups of Ca2+ indicators: synthetic fluores-
cence Ca2+ sensors and genetically encoded Ca2+ indicators (GECIs). The synthetic fluorescence
Ca2+ sensors cover a large range of Ca2+ sensors with different fluorescent excitation/emission
spectra, dynamics and capacities. Fura-2 is a ratiometric and sensitive indicator dye for measuring
intracellular Ca2+ [51]. 340/380 nm excitation ratio for Fura-2 allows accurate measurements of
the intracellular Ca2+ concentration. Fluo-3 and Fluo-4 are visible-light excitated. They have an
absorption spectrum compatible with excitation at 488 nm by argon-ion laser sources and a very
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large fluorescence intensity increase in response to Ca2+ binding. X-rhod-1 is a red dye (excitation
peak at 576 nm and emission peak at 602 nm) with rather low affinity to Ca2+ with Kd of 700 nM.
GECIs are an alternative to synthetic Ca2+ indicators. GECIs can be easily targeted to specific
cell types or subcellular compartments with tissue specific promoter. As they are expressed by cells,
they are compatible with long-term, repeated in vivo measurements. GECIs consist of Ca2+-binding
domain such as calmodulin or troponin C (TnC), fused to either one or two fluorescent proteins.
In GECIs with two fluorescent proteins, Ca2+ binding modulates fluorescence resonance energy
transfer (FRET) between fluorescent proteins. And in GECIs with single fluorescent protein, the
fluorescence intensity of a circularly permuted fluorescent protein (cpFP) is modulated by Ca2+
binding-dependent changes in the chromophores environment. GCaMP3, which is used in this
thesis, is a GECI with one fluorescent protein. It utilizes permuted enhance green fluorescent
protein (eGFP) as the fluorophore and interaction between M13 and calmodulin to sense Ca2+
change. GCaMP3 is improved based on GCaMP2 (at M153K and T203V sites, numbers refer to
residue sequence of the fluorophore eGFP, [136]) and it is brighter, has greater protein stability,
has a large dynamic range and higher affinity for Ca2+. To detect nuclear Ca2+ change, GCaMP3
is targeted to nuclei with a nuclear localization sequence (NLS) under CaMKIIα promoter to be
specifically expressed excitatory pyramidal neurons.
1.3 Activity-mediated Neuron Protection
Physiological levels of synaptic activation are required for neurons to survival and neural circuits
have to maintain stable function in front of various plastic challenges. But unfortunately, many of
our normal and vital functions are lost due to decrease of neuronal activity such as Alzheimer’s
disease (AD), which is characterized by progressive impairment of cognition and emotional dis-
turbance and they are strongly correlated with decreased synapse density in limbic structure like
hippocampus and neocortex [75]. Procedures which interfere with electrical activity and compro-
mise NMDA receptor function or nuclear calcium signaling can have deleterious effects on the
health of neurons both in vitro and in vivo. For instance, intraperitoneal injection of the NMDA
receptors antagonist MK-801 to block NMDA receptor function in vivo in seven day-old rats trig-
gers a wave of apoptotic neurodegeneration in many brain regions within 24 hours. These regions
include the parietal and frontal cortex, the thalamus and the hippocampus [68]. Likewise, selec-
tively blocking nuclear calcium signaling prevents cultured hippocampal neurons from building up
anti-apoptotic activity upon synaptic NMDA receptor stimulation. On the other hand, neuronal
activity can boost neuroprotection. Enhancing neuronal firing, especially synaptic NMDA receptor
activity, is neuroprotective: cultured hippocampal neurons which have experienced periods of ac-
tion potential bursting causing calcium entry through synaptic NMDA receptors are more resistant
to cell death-inducing conditions [62]. Moreover, stimulating synaptic activity in vivo by exposing
rats to enriched environments reduces spontaneous apoptotic cell death in the hippocampus and
protects against neurotoxic injuries [149]. Activity-dependent neuroprotection is induced by cal-
cium entry through synaptic NMDA receptors and requires that calcium transients invade the cell
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nucleus [107]. A pool of activity-regulated genes have been identified which provide neurons with
a robust neuroprotective shield against cell death [157].
1.4 Optogenetics and ChR2
Optogenetics refers to the integration of optics and genetics to achieve gain- or loss-of-function
(GOF or LOF) of well-defined events within specific cells of living tissue [147]. The very original
aspects of the conceptual inspiration for optogenetics can be traced back to the 1970s [36]. But due
to some fundamental caveats for a possibility for optical control of nervous system, it took quite
a long time for its experimental implementation. The integration of the idea into neuroscience
research only started blooming when ChR2 was identified as a directly light-gated cation channel
[99] at the beginning of the 21st century.
1.4.1 Optogenetic Toolbox
Organisms ranging from archaebacteria to human beings capture energy and/or information con-
tained within environmental sources of light by using photoreceptors called rhodopsins, which con-
sist of seven-transmembrane-helix proteins, called opsins, covalently linked to retinal. On the basis
of primary sequences, the corresponding opsin genes classified into two groups: microbial (type I)
and animal (type II). Type I genes are found in archaea, eubacteris, fungi and algae, whereas type
II proteins are expressed in animals, including human beings. The type II proteins indirectly in-
fluence transmembrane ion currents by coupling to G-protein based signal transduction pathways.
Different from the animal type of rhodopsin, the type I proteins (microbial rhodopsin) are not cou-
pled to G-protein-based signal transduction pathway but themselves include direct-light-activated
regulators of transmembrane ion conductance, such as the light-driven ion pumps called bacteri-
orhdopsins and halorhodopsins (BRs and HRs) and the light-driven ion channels (ChRs) [73]. BR
is highly expressed in haloarchaeal and serves as part of an alternative energy-production system.
BRs pump protons from the cytoplasm to the extracellular medium to form a proton-motive force
to drive ATP synthesis. They can support hyperpolarization when expressed in neurons [112]. HRs
are light-driven inward chloride pump and can support the quieting of neural activity in response to
yellow light [89]. ChRs are light-driven inward nonspecific cation channels and can support neural
depolarization [98]. ChRs are rapidly introduced in neuroscience research and expression of ChRs
in neurons can support action potentials with brief, millisecond pulses of blue light [99]. These
specific proteins make a toolkit for optogenetic manipulation of nervous system.
1.4.2 Identification of ChR2
Channelrhodopsins (ChRs) are a subfamily of retinylidene proteins (rhodopsins) that function as
light-gated ion channels [98]. ChRs are derived from algae that have shown experimental util-
ity in optogenetics. They serve as sensory photoreceptors in unicellular green algae, controlling
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phototaxis, i.e. movement in response to light [124]. Expressed in cells of other organisms, they
enable the use of light to control electrical excitability, intracellular acidity, calcium influx, and
other cellular processes. Channelrhodopsin-1 (ChR1) and Channelrhodopsin-2 (ChR2) from the
model organism Chlamydomonas reinhardtii are the first discovered ChRs. Several other variants
have been cloned subsequently from other algal species, and many more are expected to be iden-
tified in the future. It was found that ChRs could be expressed in mammalian neurons to mediate
precise and reliable control of action potential firing in response to light pulses, without the need
for exogenous retinal in vertebrate systems.
The nucleotide sequences of ChR2, together with that of ChR1, were uncovered in a large-
scale EST sequencing project in C. reinhardtii. Both sequences were submitted to GenBank by
three different groups ([124, 132] and direct submission by Peter Hegemann group). Although
with different names, both sequences were found to function as single-component light-activated
cation channels in a heterologous system [98, 99]. The name "channelrhodopsins" was coined to
highlight this unusual property, and the sequences were renamed accordingly. Meanwhile, their
roles in generation of photoreceptor currents in algal cells were characterized by John Spudich
group [124].
1.4.3 Engineering of ChR2
To date, optogenetic application of microbial opsin genes benefited substantially from molecular
modification. Through a combination of molecular engineering and genomic discoveries of new
light-sensitive proteins, the toolkit of neuron modulators is rapidly improving in specificity and ver-
satility. With its specific fast depolarization function in neurons, ChR2 is the most widely studied
and used in neuroscience research field. With molecular mutagenesis studies, ChR2 function has
been engineered to have faster or extended open-state lifetimes, shifted absorption spectra, reduced
desensitization, and increased expression and photocurrent magnitude.
Wild type ChR2 is a direct light-switched cation-selective ion channel. It opens rapidly af-
ter absorption of a photo to generate a large permeability for monovalent and divalent cations.
ChR2 desensitizes in continuous light to a smaller steady-state conductance. Recovery from de-
sensitization is accelerated by external H+ and negative membrane potential, whereas closing of
the ChR2 ion channel is decelerated by intracellular H+ [99]. After detailed sequence compar-
isons with the well-characterized BR, Karl Deisseroth group found out the residue C128 (cysteine
residue at 128 site of ChR2 protein sequence) to be critical for determining the channel kinetics
[13]. Single point mutation of cysteine to alanine or serine at 128 site (ChR2-C128A/S, C128A is
used in this work and termed as ChR2-a) produced a bi-stable neural state switches. ChR2-a opens
longer upon blue light activation but the photocurrent is relatively lower compared to wild type
ChR2. ChR2-a has faster activation kinetics and superior inactivation by green light, granting it as
a step-function opsin (SFO), and is very useful for light-controlled induction of immediate early
genes [118]. Structure analysis revealed that the photocycle of ChR2 is largely influenced by the
putative hydrogen bond between C128 and D156 [10]. Mutation at D156 to alanine has similar
effect to C128A, with increased light sensitivity but slowed kinetics. Biophysical characterization
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revealed that the the kinetics of ChR2 slows down considerably at depolarized membrane potential
[97]. E123T substitution of ChR2 (ChR2-e) abolishes this voltage sensitivity and speeds up chan-
nel kinetics [52]. Because the single channel conductance of ChR2 is very small, high expression
levels are required to fire neurons reliably. With a screening of a large number of ChR2 point mu-
tants, Andre Berndt and colleagues discovered a dramatic increase in photocurrent amplitude after
threonine-to-cysteine substitution at position 159 ([12], ChR2-T159C, termed as ChR2-b in this
work). ChR2-b generates very large photocurrents and sensitizes neurons to very low light inten-
sities. Due to the relatively small photocurrent, many optophysiological experiments are limited.
Combination of E123T and T159C produced a double mutant (ChR2-be) enabling reliable and sus-
tained optical stimulation of hippocampal pyramidal neurons up to 60 Hz. Another variant of ChR2
called calcium translocating channelrhodopsin (CatCh [74], ChR2-c in this work) having a point
mutation at L132C mediates an accelerated response time and a voltage response that is about 70
fold more light sensitive than that of wild type. ChR2-c has enhanced Ca2+ permeability leading
to its superior properties. An increase in Ca2+ concentration elevates the internal surface potential,
facilitating activation of voltage-gated Na+ channels and indirectly increasing light sensitivity. The
different variants of ChR2 made/used in this thesis work are listed in Table 2.2.
1.5 Gene Delivery with AAV
Adeno-associated virus (AAV) is a single stranded DNA, non-pathogenic (replication defective),
non-enveloped virus. Depending on the co-infection of an unrelated helper virus (e.g. adenovirus,
herpesvirus, human cytomegalovirus, or papillomavirus) AAV is classified to the Parvoviridae fam-
ily, the genus Dependovirus. Wild-type AAV contains a DNA genome of approximately 5 kb,
which is packaged into an icosahedral, non-enveloped capsid. AAV genome contains three func-
tional regions: two open reading frames (ORF) including rep for un-structural proteins and cap for
structural capsid proteins and the inverted terminal repeats (ITR). ITRs form two T-shaped struc-
tures at the 5 and 3 ends of the AAV genome, serve as origin of replication and play a key role in
viral genome integration into the host genome as well as in the subsequent rescue of viral DNA
from the integrated state. Rep codes for a family of multifunctional nonstructural proteins that are
involved in viral/vector genome replication, transcriptional control, integration and encapsidation
of AAV genomes into preformed capsids. Cap codes for the three capsid proteins, VP1, VP2, VP3,
which share most of their amino acid sequences except for the N-terninus. Differences among the
capsid protein sequence of the various AAV serotypes results in the use of different cell surface
receptors for cell entry. In combination with alternative intracellular processing, this gives rise to
distinct tissue tropisms for each AAV serotype.
1.5.1 Advantages and Drawbacks
Due to lack of pathogenicity, AAV receives a lot of interest from gene therapy researchers. It can
infect dividing and also non-dividing cells and has the ability to stably integrate into the host cell
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genome at a specific site, the 19th chromosome in human without any known side-effects. Another
advantage of AAV is that it presents very low immunogenicity, and no cytotoxic response has
been clearly defined. Recombinant forms of AAV (rAAV) were quickly developed once the latent
form and nonpathogenic nature of AAV were discovered. On the other hand, AAV shows some
disadvantages. The cloning capacity of the vector is relatively limited (3-4 kb). Large genes are,
therefore, not suitable for use in a standard AAV vector. AAV mediated transgene expression is
delayed, often it takes 1 to 3 weeks.
1.5.2 AAV Serotypes
Tissue specificity of AAV infection is determined by the capsid serotype. So far, 14 AAV serotypes
and multiple variants have been described. Humans are the primary hosts of nine serotypes (AAV1-
9) with approximately 80% of the human population testing positive for the most common subtype,
AAV2 [140]. AAV2 is the one which has been most extensively examined so far and rAAVs are
most commonly derived from it. AAV2 presents natural tropism towards skeletal muscles, neurons,
vascular smooth muscle cells and hepatocytes. The primary cell receptor for AAV2 is heparan
sulfate proteoglican (HSPG) [129]; also some other co-receptors are defined, like Vβ5 integrin
[128], hepatocyte growthfactor receptor (HGFR)and fibroblast growth factor receptor 1 (FGFR-1)
[111]. AAV serotypes other than AAV-2 have shown superior transduction efficiencies for various
tissues. For example, AAV-1 is reported to be more efficient than AAV-2 in transducing muscle,
arthritic joints, pancreatic islets, heart, vascular endothelium, CNS and liver cells, while AAV-3
is well suited for infecting cochlear inner hair cells, AAV-4 for brain, AAV-5 for CNS, lung, eye,
arthritic joints and liver cells, AAV-6 for muscle, heart and airway epithelium, AAV-7 for muscle
and AAV-8 for muscle, pancreas, heart and liver. For research and clinical usage, the recombinant
AAV genome has the wild-type rep and cap ORFs, which constitutes 96% of the wild-type genome,
replaced with a transgene-expression cassette. When the rAAV vectors are produced, the rep, cap
and helper virus elements are supplied in trans via co-transfection of a number of helper plasmids.
rAAV vectors appear to have a tropism for neuronal cells when injected into the central nervous
system (CNS), but can also infect some non-neuronal cell types at much lower efficiencies [91].
In this thesis work, I use rAAV with a mosaic capsid (rAAV1/2) which consists of a mixture
of unmodified capsid proteins from two different serotypes: AAV1 and AAV2. AAV1 and AAV2
cap genes share more than 80% identity at the amino acid level. During viral assembly, the two
serotype capsid proteins are theoretically mixed in each virion at ratios of the contributing helper
plasmids. The capsid proteins are provided in equal proportions using separate helper plasmids
during the packaging process: AAV1 helper (pH21) and AAV2 (pRV1) helper. The AAV1 helper
includes the AAV2 rep gene and AAV1 cap gene while the AAV2 helper carries AAV2 rep gene
and AAV2 cap gene. Since AAV2 capsid proteins would be incorporated into the chimeric virion,
we could purify those viruses by heparin affinity chromatography. The mosaic viruses show high
infection efficiency and specific neuron tropism.
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1.6 Motivation
During development, neuronal activity mediates the formation of the nervous system and neural
circuits. In postmitotic neurons, activity continues playing a pivotal role as it mediates activity-
dependent morphogenesis, adaptation to the environment, and neuronal protection. Recently it was
shown that synaptic activity can boost neuroprotection through induction of a pool of calcium-
regulated genes [156] or inhibition of pro-cell-death gene like p53 [80]. Conversely, interference
with synaptic activity can have deleterious effects on the health of neurons and functions of the
whole system. In Alzheimer’s disease (AD), the strongest anatomical correlate of the degree of
clinical impairment is the synapse loss. This loss is thought to be due to the partial blockage of
N-methyl-D-aspartate (NMDA)receptors activity and NMDA receptors mediated calcium influx by
amyloid-beta (Aβ) oligomers [119]. Loss of neurons in limbic structures, such as the hippocam-
pus and the amygdala, and associated regions of the cerebral cortex are reported to be strongly
correlated with the onset of AD. Additionally, similar synaptic degeneration and cell loss are also
observed in aged rats [110]. Intriguingly, recent results show that activated neurons are better able
to withstand aging and AD [133]. Indeed, synaptic activity can induce rapid dendritic morphogen-
esis in CA1 hippocampal neurons [87]. Likewise, stimulating synaptic activity in vivo by exposing
rats to enriched environment (EE) produced a robust increase in hippocampal synapse numbers in
adult mice [46]. Modulating neuronal activity is a promising way to initiate downstream effects
against degeneration of synapses and cell death [87, 156]. Therefore, it would be very encouraging
to try to restore activity of specific groups of neurons before the onset of those symptoms in neu-
rodegenerative disorders and aging. The discovery and introduction of channelrhodopsin2 (ChR2)
into the field of neuroscience inspired our activity-restoring strategy. ChR2 is a light-gated, cation-
selective, small membrane channel isolated from Chlamydomonas reinhardtii. The direct gene
products are apoproteins Channelopsin 2 (Chop2) that form ChR2 when reconstituted with the
chromophore all-trans-retinal (ATR). Chop2 has a 7-transmembrane helix and a long C-terminal
extension. Expression of the N-terminal transmembrane fragment is sufficient for the formation
of a functional channel in mammalian cells when ATR is present [99]. An advantage of the ge-
netically encoded modulator, ChR2, is that it can be easily targeted to certain types of cells with
tissue-specific promoters. Furthermore, ChR2 is fully functional without any additional cofactors
when expressed in neurons in vitro and in vivo. Integration of ChR2 into the plasma-membrane
does not alter the intrinsic properties of the host neuron. This channel is activated with blue light
with the maximal excitation wavelength at 460nm, which is easily obtained with a standard green
fluorescence protein (GFP) filter setup, and it will give reliable, millisecond-timescale control of
neuronal spiking, as well as control of excitatory and inhibitory synaptic transmission [23]. ChR2
has been broadly used to activate the neural circuitry in vitro and in vivo [7]. In this thesis, ChR2 is
used as a tool to introduce increased neuronal activity to neurons and analyze the potential benefi-
cial downstream effects, including activated signaling pathways, induction of gene expression and
neuron protection. ChR2 is also targeted to intracellular membrane system to directly induce Ca2+
transients there. Neural activity is induced in another pharmacology way using Bic, a competitive
antagonist of GABAA receptors, to induced synchronized bursting of action potentials and analyze
the minimal activity requirement for gene transcription initiation.
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Chapter 2
Materials and Methods
2.1 Cloning
2.1.1 Subcloning into AAV Vector
DNA plasmids coding for ChR2 and its mutants were from: Karl Deisseroth, Department of Bio-
engineering and Howard Hughes Medical Institute, Stanford University, California, USA, for the
hChR2; Thomas G. Oertner, Friedrich Miescher Institute for Biomedical Research, Basel, Switzer-
land, for the ChR2-C128A mutant; Peter Hegemann, Institute of Biology, Experimental Bio-
physics, Humboldt-University, Berlin, Germany, for the ChR2-T159C mutant.
To adapt these DNAs into our AAV expression system, the coding sequences were subcloned into
the AAV expression vector with CaMKIIα promoter. As shown in Figure 2.1, ChR2 was sub-
cloned into the AAV vector with the BamHI and NheI restriction sites. Primers used for amplifying
ChR2 fragment were: forward primer P55, 5′-GCGGATCCGTATGCCAAGTAGG-3′ and reverse
primer P71, 5′-CGGCTAGCTACCGCGCCAG-3′. HA, eGFP and mCherry tags were used for dif-
ferent purposes. The AAV vector had a human growth hormone polyA (hGH polyA) for stabilizing
mRNA , Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element (WPRE) to enhance
expressing level and two inverted terminal repeats (ITRs) for virus wrapping.
2.1.2 Point Mutation
Overlap extension PCR method was used to make double mutant on the base of another existing
mutant we got from other labs. The idea of overlap extension PCR method was to design the point
mutation in two opposite directional primers. In the case of introducing C128A point mutation
to ChR2-T159C sequence, primers were P79, 5′-GAATGAGAATGACCGGGGCGGTGAGAAG-
3′ and P80, 5′-CTTCTCACCGCCCCGGTCATTCTCATTC-3′, where the italic nucleobases were
the coding for Cysteine (C) to Alanine (A) mutation. In combination with another two primers at
the beginning and end of the fragment (P55, 5′-GCGGATCCGTATGCCAAGTAGG-3′ and P71,
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Figure 2.1: Schematic representation of AAV vector map carrying ChR2 coding sequence. ChR2 and fluo-
rescent tag (mCherry or eGFP) is under the control of alpha-Ca2+/calmodulin-dependent protein
kinase (CaMKIIα) promoter and followed by Wookchuck Hepatitis Virus posttranscriptional
Regulatory Element (WPRE) and human Growth Hormone polyA (hGH polyA). The whole
fragment is flanked with two inverted terminal repeats (ITR). Amp+ gives resistance to ampi-
cillin and serves as a selective marker.
5′-CGGCTAGCTACCGCGCCAG-3′ for ChR2. Underlined nucleobases were BamHI and NheI
restriction sites, respectively.), two PRC fragments were produced in the first round of PCR, cutting
at the mutated point with some overlap. In the second round of PCR, products from the first PCR
were used as template and the primers for whole ChR2 (P55 and P71) were used to get the whole
coding sequence with the introduced point mutation. The detailed process for construction was
presented in Figure 2.2. PCR machine used in this work were: Peltier Thermal Cycler-200 from
MJ research and C1000TM Thermal Cycler from Bio-Rad.
Phusion R© (Finnzymes, Thermo Scientific) high-fidelity DNA polymerase was used for all the
PCR reactions in this work to ensure accuracy of the sequence. Nevertheless, all plasmids after
cloning were sequenced by GATC Biotech. The PCR composition setup and program setting for
the PCRs were shown in Table 2.1.
After each PCR, products were mixed with 6x loading buffer and loaded in a 1% agarose gel for
electrophoresis, at 120 V for 30 min. Product band size was checked under UV light and expected
band was collected for gel extraction and purification.
Both the PCR products from the 2nd PCR and the AAV vector were digested with BamHI
and NheI. The entire purification product and 2 µg of vector were used in this digestion. They
were digested according to enzyme manual in the 1x Tango buffer at 37◦C for 2 h. The digestion
products were loaded in an agarose gel and the bands of interest were cut out for a gel extraction.
Purified fragments from gel extraction were used in the following ligation. For each reaction,
the mole ratio between insert and vector was 3:1. Quick ligation system (Fermentas) was used. A
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Figure 2.2: Schematic representation of overlap extension PCR method to generate point mutation. ChR2-b
coding sequence is used as template and 4 primers, P55, P79, P80 and P71, are used. C128A (a)
point mutation is designed in primers P79 and P80. Two DNA fragment products from the first
round of PCR are used as template for the second PCR with primers P55 and P71 to create ChR2
whole fragment harboring double mutants (ChR2-ab). ChR2-ab and target vector are digested
with BamHI and NehI separately and ligated to generate pAAV-ChR2-ab construct.
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Table 2.1: Overlap extension PCR
PCR setup PCR program
Component Volume (µl) Step Temperature Time
Templatea 1 1 98◦C 30 sec
Phusion R© HF buffer (5x) 10 2 98◦C 10 sec
dNTP mix (10 mM) 2 3 x◦Cb 30 sec
Primer Forc (20 µM) 5 4 72◦C 30 sec
Primer Revc (20 µM) 5 5 Go to step 2 for 30 cycles
Phusion R© DNA polymerase (2 U/µl) 0.5 6 72◦C 10 min
H2O up to 50 7 4
◦C for ever
a Totally 100 to 200 ng template DNA was used for PCR. Template DNA was adjusted to be 200 ng/µl.
For the 1st PCR, ChR2-b plasmid was used as template for getting both fragments. Purified products
from the first round of PCR were used as template for the 2nd PCR with the equal mole ratio.
b Different annealing temperature was used according to the melting temperature (Tm) of the primers.
c Forward and reverse primers were used accordingly. For making C128A on base of T159C, P55+P79
and P80+P71 were used for the 1st PCR; P55+P71 for the 2nd PCR.
20 µl total volume including the insert, vector, 10 µl 2x quick ligation buffer and 400 U T4 ligase
(NEB) was incubated at room temperature for 0.5 h.
DH5α competent cells were transformed with the ligation product. Briefly, DNA and competent
bacteria cells were mixed, put on ice for 0.5 h and then heat shocked at 42◦C for 90 sec. The
bacteria were cooled down on ice for 3 min. 800 µl antibiotic-free lysogeny broth (LB) was added
and the bacteria were amplified at 37◦C for 1 h with shaking at 225 rpm (CERTOMAT R© R,
B. Braun Biotech International). The bacteria were spun down at 800 rpm for 5 min and plated
on antibiotic (kanamycin, Kana+, 50 µg/ml or ampicillin, Amp+, 100 µg/ml) containing LB agar
plates. Plates were incubated at 37◦C overnight. Colonies from the plates were picked up and
dissolved in 15 µl of LB. 1 µl of it was used as the template for PCR with primer to check whether
the interested fragment was incorporated in the new construct. The positive colonies which had a
band at the expected size were amplified for plasmid miniprep and then digested with BamHI and
NheI to check the correct insertion. Positive colonies were sent for sequencing.
In this work, mutants of ChR2 were coded as in Table 2.2
2.2 AAV Production
2.2.1 HEK Cell Culturing
Human embryonic kidney 293 (HEK-293, American Type Culture Collection, CRL1573) cells
were used for AAV production. These cells were cultured in flasks with DMEM-complete medium
(Table 2.3), split in the dilution of 1:5 and passaged every 3 to 4 days. For splitting, culturing
medium was removed and the cells were washed twice with phosphate buffered saline (PBS). After
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Table 2.2: ChR2 mutants
Name Mutation Properties
wt Wild type Cation selective ion channel.
a C128A Step function opsion (SFO), long opening.
b T159C Larger permeability.
ab a+b Longer opening with larger current.
c L132C CatCh, Ca2+ trnslocating channelrhodopsin.
be b+E123T High-efficient ChR2.
ad a+D156A Super SFO.
removing PBS, 0.05% Trypsin-EDTA (Gibco R©) was added directly to the cells and the flask was
incubated at 37◦C for 5 min. After trypsin digestion, the same volume of DMEM-complete was
added to the flask to stop the enzyme digestion procedure. Cells were then suspended and collected
in falcon tube. The cell solution was spun at 800 g, at room temperature for 5 min. After spinning,
the medium was removed and the cells were resuspended in fresh DMEM-complete, with a flamed
pipette Pasteur to get signal cell solution, and plated in a new flask. All the medium used should be
pre-warmed at 37◦C.
Table 2.3: Dulbecco’s Modified Eagle Medium-complete (DMEM-complete),
500 ml
Solutiona Volume (ml) Note
DMEM 500 include 4.5 g/l glusoce
FBS/FCS 50 heat inactivatedb
NEAA 5 non essential amino acids, 100x
Sodium pyruvate 5 100 mM, 100x
Pen/Strepc 2.5
a All from GIBCO R©.
b FBS (fetal bovine serum) or FCS (fetal calf serum) was incubated at 56◦C for 30
min.
c Penicillin G sodium, 10,000 unite/ml; streptomycin sulfate, 10,000 µg/ml in 0.85%
saline.
2.2.2 HEK Cell Transfection with Ca2+-phosphate
Ca2+-phosphate transfection protocol was used to transfect HEK293 cells for producing virus. The
cells were seeded into 150 cm dishes (TC Dish 150x20 NUNC) containing DMEM-complete. At
transfection start point, cells should be about 70% confluent. 3 hours before the transfection,
DMEM-complete was replaced with pre-warmed IMDM-complete (Table 2.4). All transfection
reagents were warmed up to room temperature before use. Five 150 cm dishes were used for pro-
ducing one virus. And for one virus, the following reagents were used: 12 ml sterile H2O; 1650 µl
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2.5 M CaCl2; 62.5 µg AAV transgene plasmid with genes of interest, 125 µg adenoviral helper plas-
mid (pFdelta6), 31.25 µg AAV helper (pH21, with cap gene for AAV serotype 1 and rep gene for
AAV serotype 2) and 31.25 µg AAV2 helper (pRVI, with cap and rep genes for AAV serotype 2);
this pre-mixture was prepared in an order as H2O, CaCl2 and then plasmids; the mixture was filtered
through a 0.2 µm syringe filter into a small sterile bottle. 13 ml 2x HeBs (HEPES buffered saline,
see Table 2.5) were added to the mixture while vigorously vortexing for 15 seconds. Very fine and
white precipitate formed after 2 min. 5 ml of this transfection mixture was added drop-wise in a
circular motion to each plate. Plates were swirled carefully and returned to incubator with 5% CO2
supply at 37◦C. 16 to 20 hours later, Ca2+-phosphate precipitation was checked and could be seen
under microscope. The transfection medium was changed back to pre-warmed DMEM-complete.
Cells were then put back into the incubator.
Table 2.4: Iscove’s Modified Dulbecco’s Medium-
complete (IMDM-complete), 500 ml
Solution Volume(ml)
IMDM 500
FBS/FCS, h.i.a 50
a h.i., heat inactivated, FBS (fetal bovine serum) or FCS (fetal
calf serum) was incubated at 56◦C for 30 min.
Table 2.5: 2x HeBs
Component Concentration (mM)
HEPES 50
NaCl 280
Na2HPO4 1.5
a Adjust pH to 7.05. It is very critical for successful
transfection.
b Sterile filtered through 0.22 µm Millipore filter, aliquote and
store at -20◦C.
2.2.3 Virus Harvesting
About 60 hours after transfection, cells were washed with pre-warmed PBS once, harvested in 25 ml
PBS/plate by scraping and pelleted by centrifugation at 800 g for 5 min. Pellets were resuspended
in 150 mM NaCl/20 mM Tris (pH 8.0), 50 ml/virus and frozen at -20◦C. On the next day, cell
pellets were thawed at room temperature and lysed by treating them with 50 U/ml Bensonase and
0.5% sodium deoxycholate for 1 hour at 37◦C with mixing every 10 min. Cell debris was removed
by centrifugation at 3000 g for 15 min, 4◦C.The supernatant was transferred into a new tube and
frozen at -20◦C for purification.
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2.2.4 Virus Purification
Heparin column was used to purify the virus. Virus sample was defrosted at room temperature
and centrifuged at 3000 g for 15 min, 4◦C to get rid of any possible debris. Heparin column was
pre-equilibrated with 10 ml 150 mM NaCl/20 mM Tris (pH 8.0) with help of a pump at 1 ml/min
flow rate. 50 ml sample solution from each virus was then loaded onto the column at 1 ml/min rate
using a 60 ml syringe. The column was washed with 20 ml 100 mM NaCl/20 mM Tris (pH8.0)
also at the rate of 1 ml/min. Following wash and elution steps were done manually as the volume
was much smaller. The column was washed with 1 ml 200 mM NaCl/20 mM Tris (pH8.0) and then
1 ml 300 mM NaCl/20 mM Tris (pH8.0) at a rate about 1 ml/min. Then it was eluted with 1.5 ml
400 mM NaCl/20 mM Tris (pH8.0), 3 ml 450 mM NaCl/20 mM Tris (pH8.0) and 1.5 ml 500 mM
NaCl/20 mM Tris (pH8.0). Eluted virus was collected in a 15 ml sterile tube. The purified virus
solution was concentrated using Amicon Ultra-4 (Millipore) concentrators at 2000 g for 2 min and
then washed twice with 3.5 ml PBS. After concentration, around 250 µl virus solution was left in
the concentrator and transferred into a 1.5 ml tube. Finally, the virus was sterilized by filtration
through a 0.2 µm/13 mm diameter syringe filter.
2.2.5 Virus Testing
Ready-to-use virus was firstly check by the purity of capsid proteins. Briefly, 5 µl virus was lysed
with sample buffer and loaded to a 12% SDS-PAGE (Sodium Dodecyl Sulfate Polyacrylamide Gel
Electrophoresis). Protein separation was performed by electrophoresis with constant current at 30
mA for 1 h. Then the gel was stained with coomassie blue superstain solution (Table 2.6) at room
temperature for 45 min and destained (Table 2.6) for about 3 hours till the bands were clear.
Virus was further tested in cultured hippocampal neurons to check the infection efficiency and
toxicity to neurons. Normally, cells were infected on day in vitro (DIV) 4, fixed on DIV 10. The
infection efficiency was calculated as virus positive cell to total cell number.
Table 2.6: Coomassie blue superstain & destain solution
Superstain Destain
Component (w/v or v/v) Component (v/v)
Coomassie blue R250 0.1% Acetic acid 10%
Acetic acid 10% Isopropanol 10%
Methanol 50%
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2.3 Hippocampal Culture
2.3.1 Hippocampal Culture Preparation
Dissociated hippocampal neuronal cultures were prepared from new-born wild type C57BL/6 pups.
Hippocampi were dissected free from the rest of the brain in a mixture solution from Ky/Mg so-
lution (Ky/Mg, Table 2.7) and dissociation medium(DM, Table 2.8) at 1:9 volume ratio (e.g. 5 ml
Ky/Mg and 45 ml DM, referred to as Ky/Mg/DM). Hippocampal tissue was then dissociated by en-
zyme solution (Papain latex 10 Units/ml and 3.7 mM L-Cysteine in Ky/My/DM) for 20 min at 37◦C.
During incubation, the tube was stirred every 5 min to make it homogenous and to avoid it become
yellow. This enzyme incubation was done twice with an enzyme solution change in between. En-
zyme activity was stopped by trypsin inhibitor solution (1% , w/v trypsin inhibitor in Ky/My/DM).
Inhibition was performed 3 times with complete inhibition solution change in between and each
time was incubated at 37◦C for 5 min. After enzyme inhibition, hippocampi were washed 3 times
with growth medium (GM, Table 2.10) and then triturated by pipeting to get single cell suspen-
sion. This cell suspension was diluted in Opti-MEM (supplemented with 20 mM Glucose) to get
a concentration about 0.8 hippocampus/2 ml. Cells were plated on poly-D-lysine/laminin (BD
Biosciences) coated 35-mm plastic dishes (2 ml/dish, containing 12-mm diameter glass coverslips
or not according to different experiment design). 2.5 hours after plating, medium was replaced
with fresh neurobasal-A/growth medium (Table 2.10, 2 ml/dish) and put back to a 37◦C incubator
supplied with 5% CO2.
2.3.2 Hippocampal Culture Maintenance
AraC (cytosine β-D-arabinofuranoside, Sigma-Aldrich, C1768) was added on DIV 3 at a final
concentration of 2.8 µM to inhibit the proliferation of non-neuronal cells. On DIV 8, GM was
changed to transfection medium (TM: 10% MEM, ITS containing 7.5 µg/ml Insulin, 7.5 µg/ml
Transferrin, 7.5 ng/ml Sodium selenite, 50 Units/ml Penicillin, 50 mg/ml Streptomycin, in SGG.
See Table 2.11). If the experiments last longer than 10 days, medium was half changed every other
day from DIV 10 on.
Table 2.7: Ky/Mg solution (Ky/Mg)
Componenta Final Stock For 80 ml
concentration concentration
Kynurenic acid 10 mM Powder 158.56 g
MgCl2 100 mM 2 M 4 ml
HEPES 5 mM 1 M 0.4 ml
Phenol Red 0.5% 100% 0.4 ml
NaOH 12.5 mM 1 N 1 ml
H2O up to 80 ml
a All chemicals are from Sigma-Alrich Chemie GmbH, München, Germany.
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Table 2.8: Dissociation Medium (DM)
Component Final Stock Volume (ml)
concentration concentration for 250 ml
Na2SO4 81.8 mM 1 M 20.45
K2SO4 30 mM 0.25 M 30
MgCl2 5.85 mM 1.9 M 0.77
CaCl2 0.25 mM 1 M 0.063
HEPES 1 mM 1 M 0.25
Glucose 20 mM 2.5 M 2
Phenole Red 0.2% 100% 0.5
H2O up to 250
Table 2.9: Salt Glucose Glycine Solution (SGG)
Component Final Stock Volume (ml)
concentration concentration for 500 ml
NaCl 114 mM 5 M 11.4
NaHCO3 0.22% 7.5% 14.6
KCl 5.29 mM 3 M 0.882
MgCl2 1 mM 1.9 M 0.264
CaCl2 2 mM 1 M 1
HEPES 10 mM 1 M 5
Glycine 1 mM 1 M 0.5
Glucose 0.54% 45% 6
Sodium pyruvate 0.5 mM 0.1 M 2.5
Phenole Red 0.2% 100% 0.5
H2O up to 500
Table 2.10: NB-A/Growth Medium (GM)
Component Volume (ml)
Neurobasal A-medium 97
B27 2
Rat serum 1
Glutamin(200 mM) 0.25
Pen/Strep 0.5
H2O up to 100
sterile filtered through 0.22 µm Millipore filter and store at
-4◦C.
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Table 2.11: Transfection Medium (TM)
Component Volume (ml)
SGG 88
MEM (without glutamine) 10
ITS 1.5
Pen/Strep 0.5
H2O up to 100
sterile filtered through 0.22 µm Millipore filter and store at
-4◦C.
2.4 Transfection and Infection
2.4.1 Neuron Transfection with Lipofectamine2000
LipofectamineTM 2000 transfection was carried out to transfect hippocampal neurons. For a 35 mm
dish containing 4 coverslips, 5 µl LipofectamineTM 2000 (InvitrogenTM) was diluted in 100 µl TM,
and the mixture was vortexed to get homogenous solution. 1.6 µg plasmid DNA was diluted in
another 100 µl TM and pipetted up and down. The Lipofectamine and DNA mixture made above
were mixed together and left at room temperature for 30 min. Then another pre-warmed 800 µl TM
was added to each tube to get the final transfection solution. Growth medium was replaced with the
transfection solution. Cells were put back to the incubator for 2.5 to 3 hours. Then, the transfection
solution was removed and 2 ml fresh TM was added to the dish. Constructs were expressed for 24
h or 48 h before stimulation or imaging experiments.
2.4.2 Neuron Infection with AAV
Infection of cultured neurons was normally performed on DIV 4. For the infection, virus was first
aliquoted with certain amount into a 1.5 ml eppentube. Then some culturing medium was put into
the tube and mixed well with virus. The virus solution was put back into cells.
2.5 Q-PCR
To determine the mRNA levels of activity related genes in mouse culture, quantitative PCR (Q-
PCR) was performed using TaqMan R© Prob-Based Gene Expression Analysis technology with a
sequence detection system model 7300 Real Time PCR machine (Applied Biosystems R©).
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2.5.1 RNA Extraction
All RNA related work was done under RNase-free condition. Total RNA was extracted using
RNeasy Plus Mini Kit (Qiagen) with additional on-column DNaseI digestion (RNase-Free DNase
Set, Qiagen) during RNA purification. Briefly, cell samples were lysed with lysis buffer (RLT)
supplemented with 1% β-mercaptoethanol (β-ME). For each 3.5 cm dish, 600 µl + 6 µl β-ME was
used and β-ME was always added in freshly. Cells were then scraped thoroughly, collected into
the tube and mixed by vortexing for 30 sec. Equal volume (600 µl for each) of 70% Ethanol was
added to the homogenized lysate and mixed well by pipetting. The sample was transferred on to
an RNeasy spin column placed in a 2 ml collection tube and spun for 15 sec at 13,000 rpm (round
per minute). The flow through was discarded. The column membrane was washed with 350 µl
RW1 once and spun down. The on-column DNaseI digestion was performed at room temperature
for 15 min with 80 µl DNase solution (10 µl DNaseI stock in H2O plus 70 µl RDD buffer, final
DNaseI concentration: 340 Kunitz units/ml) directly to the RNeasy spin column membrane. After
digestion, the column was washed once with 350 µl RW1 and twice with 500 µl wash buffer RPE.
The column was placed into a new collection tube and centrifuged for 2 min to get rid of all the
wash solutions. For elution, the column was placed into a new, RNase free 1.5 ml tube; 30 µl
RNase-free water was directly added to the column membrane and centrifuged for 1 min at 13,000
rpm. The eluted RNA was used for reverse transcription afterwards or stored at -80◦C for later use.
2.5.2 cDNA Synthesis
For cDNA synthesis, 1.2 µg of total RNA, random primers were used to do the reverse transcription
with High Capacity cDNA Reverse Transcription Kit (Applied Biosystems R©). Reverse transcrip-
tion was done in 20 µl volume. 1.2 µg RNA was dissolved in RNase-free H2O to a total volume
of 10 µl and reverse transcription mixture in 10 µl also. The reagents and reverse transcription
program were as shown in Table 2.12 and 2.13, respectively.
Table 2.12: cDNA synthesis mixture, 20 µl
Solution (µl)
RNA template 1.2 µg in 10 µl
RT buffer (10x) 2
dNTP (100 mM, 10x) 0.8
Random primers (10x) 2
Reverse transcriptase (50 U/µl) 1
RNase inhibitor (40 U/µl) 0.5
RNase-free H2O 3.7
Table 2.13: cDNA synthesis program
Step Temperature Duration
1 25◦C 5 min
2 37◦C 120 min
3 85◦C 5 sec
4 4◦C for ever
After reverse transcription, the products were diluted 1:6 in RNase-free H2O and used for Q-
PCR or stored at -20◦C for later use.
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2.5.3 Q-PCR
For Q-PCR assay, the diluted cDNA from above was used with TaqMan R© Universal PCR Master
Mix (Applied Biosystems R©). Ready to use probe sets designed by TaqMan R© Gene Expression
Assays, Applied Biosystems R© were used to perform the quantitative PCR. The setup of the reaction
mixture and Q-PCR program was show in Table 2.14 and 2.15, respectively. Data reading was in
the 4th step at 60◦C.
Table 2.14: Q-PCR Mixture, 20 µl
Solution (µl)
Master mix, 2x 10
Probe, 20x 1
cDNA 9
Table 2.15: Q-PCR program
Step Temperature Duration
1 50◦C 2 min
2 95◦C 10 min
3 95◦C 15 sec
4 60◦C 1 min
5 Go to Step 3 for 50 cycles
6 Stop
Each cDNA sample was assayed in duplicate and a mean cycle time value was calculated. The
expression level of the target mRNA in mouse was normalized to the relative ratio of the expression
of Gusb mRNA.
2.5.4 List of Probes
The Q-PCR probes used were listed in Table 2.16. They were all FAM (6-carboxyfluorescein)
labeled, and were designed and purchased from TaqMan R© probe-based gene expression analysis,
Applied Biosystems R©.
2.6 Western Blot
2.6.1 Western Blot
Hippocampal neuron or HEK293 cell whole cell extract were prepared in 1x sample buffer (3x
sample buffer: 9%SDS, 187.5 mM Tris, pH 6.8 and 30% glycerol in w/v. Add 10% β-ME and bro-
mophenol blue before use.) and boiled for 5 min at 95◦C before loading. Proteins were separated
with 8%-12% SDS-PAGE (Table 2.17) with constant current at 30 mA per gel (Running buffer:
190 mM glycine, 25 mM Tris, 0.1% SDS and pH 8.8) and transferred to nitrocellular membrane
(Waterman) with constant voltage at 20 V for 1.5 h (Transferring buffer: 150 mM glycine, 20 mM
Tris, 0.1% SDS and 20% Methanol). Membrane was blocked in 5% milk in PBST (0.1%Tween-20
in PBS, 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4 · 2 H2O, 2 mM KH2PO4, pH 7.4) at room
temperature for 1 h. Membrane was incubated with the primary antibodies at 4◦C overnight. On
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Table 2.16: Q-PCR probes
Acronym Gene name Assay ID
Arc activity regulated cytoskeletal-associated protein Mm00479619_g1
Atf3 activating transcription factor 3 Mm00476032_m1
Bcl6 B-cell leukemia/lymphoma 6 Mm00477633_m1
Bdnf brain derived neurotrophic factor Mm00432069_m1
Btg2 B-cell translocation gene 2, anti-proliferative Mm00476162_m1
cfos FBJ osteosarcoma oncogene Mm00487425_m1
Dnmt3a1 DNA methyltransferase 3 alpha, isoform 1 Mm00432870_m1
Dnmt3a2 DNA methyltransferase 3 alpha, isoform 2 Mm00463987_m1
Egr1 early growth response 1 Mm00656724_m1
Gadd45b growth arrest and DNA-damage-inducible 45 beta Mm00435123_m1
Gadd45g growth arrest and DNA-damage-inducible 45 gamma Mm00442225_m1
Gusb glucuronidase, beta Mm00446953_m1
Ifi202b interferon activated gene 202B Mm00839397_m1
Inhba inhibin beta-A Mm00434338_m1
Npas4 neuronal PAS domain protein 4 (Nfx) Mm00463644_m1
Nr4a1 nuclear receptor subfamily 4, group A, member 1, Nur77 Mm00439358_m1
Puma BCL2 binding component 3 Mm00519268_m1
Serpinb2 serine (or cysteine) peptidase inhibitor, clade B, member 2 Mm00440905_m1
the next day, after 4 times wash with PBST, secondary antibody was incubated at room tempera-
ture for 30 min. The membrane was then washed for 30 min using PBST with an interval of 5 min.
ECL detection was performed according to the manual (Amersham). The film was developed with
a Kodak developing machine.
Table 2.17: SDS-PAGE
Upper/Stacking Lower/Resolving gel (20 ml)
gel, 3.7% (10 ml) 8% 10% 12%
H2O 6.25 ml 9.6 ml 8.2 ml 6.9 ml
4x Buffera 2.5 ml 5 ml 5 ml 5 ml
30% ProtoGelb 1.25 ml 5.3 ml 6.7 ml 8 ml
10% APSc 100 µl 100 µl 100 µl 100 µl
TMEDE 10 µl 10 µl 10 µl 10 µl
a 4x upper gel buffer: 0.5 M Tris-HCl, pH 6.8 and 0.4% (w/v) SDS;
4x lower gel buffer: 1.5 M Tris-HCl, pH 8.8 and 0.4% (w/v) SDS.
SDS is from SERVA and both buffer should be stored at 4◦C.
b 30% ProtoGel from National Diagnostics.
c 10% (w/v) ammonium persulfate (APS) in H2O.
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2.6.2 List of Antibodies
The primary and secondary antibodies for western blot used in this thesis are listed in Table 2.18
and Table 2.19, respectively.
Table 2.18: Primary antibodies-Western Blot
Name Host species Company Dilution
BDNF rabbit polyclonal Santa Cruz, sc-546 1:1000 in 5% milk/PBST
c-Fos rabbit polyclonal Santa Cruz, sc-253 1:5000 in 5% milk/PBST
CREB rabbit monoclonal Cell Signaling, 9197 1:1000 in 5% BSA/TBST
phospho-CREB (Ser133) rabbit polyclonal Upstate, 06-519 1:1000 in 5% BSA/PBST
ERK1/2 rabbit polyclonal Cell Signaling, 9102 1:4000 in 5% BSA/PBST
phospho-ERK1/2 mouse monoclonal Cell Signaling, 9106 1:2000 in 5% BSA/PBST
tubulin mouse monoclonal Sigma, T9026 1:400000 in 5% milk/PBST
Table 2.19: Secondary antibodies-Western Blot
Name Host species Conjugate Company Dilution
Mouse goat IgG (H+L) HRP JIR, 115-035-003 1:5000 in 5% milk/PBST
Rabbit goat IgG (H+L) HRP JIR, 115-035-144 1:1000 in 5% milk/PBST
Peroxidase-conjugated affini-pure goat IgG.
JIR: Jackson ImmunoResearch.
2.7 Immunocytochemistry
Immunocytochemistry (ICC) was used to compare the protein level in individual cells within the
same or in different conditions.
2.7.1 Immunocytochemistry
Neurons were fixed with 4% paraformaldehyde (PFA) /4% sucrose at room temperature for 15
min and permeablized with cold methanol at -20◦C for 6 min. Cells were then blocked with
10% normal goat serum (NGS) in PBS at room temperature for 1 h. Primary antibodies were
diluted in 2% BSA/ 0.1% Triton-X-100/PBS. Incubation with primary antibodies was performed at
4◦C overnight. Secondary antibody was diluted in 2% BSA/ 0.1% Triton-X-100/PBS and it was
incubated at room temperature for 1 h. Nucleus was counter stained with Hoechst 33258 (Serva)
at a final concentration of 2 µg/ml for 5 min, room temperature. After several times PBS washes,
coverslips were mounted on slides.
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Immunochemistry results were examined with either Leica SP2 confocal microscopy or Le-
ica DM IRBE inverted microscope. The setting up for the confocal microscope was: 40x objec-
tive/NA1.25 oil, Zoom 1, 512 x 512 format, 8 bit resolution, xyz scan mode, 400 Hz speed, 1.0
airy pinhole, line average 1, frame average 1. The whole nucleus was scanned with z-scan at a ∆Z
of 1µm. For the intensity analysis, z-scan was used to get the maximal projection. Nucleus was
identified according to the Hoechst staining and the same regions of interest were used to get the
mean intensity value from staining projection.
2.7.2 List of Antibodies
For ICC, all antibodies used in the work were listed in Table 2.20 and Table 2.21. Antibodies were
diluted in 5% BSA/PBST and 50 µl was applied to each coverslips upside down with cell side
facing the antibody on parafilm.
Table 2.20: Primary antibodies-Immunocytochemistry
Name Species Company Dilution
CaM mouse monoclonal Upstate, 05-173 1:500
c-Fos rabbit polyclonal Santa Cruz, sc-253 1:500
phospho-CREB (Ser133) rabbit polyclonal Upstate, 06-519 1:500
Table 2.21: Secondary antibodies-Immunocytochemistry
Name Host species Conjugate Company Dilution
Mouse goat Alexa594 Invitrogen 1:500
Rabbit goat Alexa594 Invitrogen 1:500
Mouse goat DyLight488 Dianova 1:500
Rabbit goat DyLight488 Dianova 1:500
2.8 Ca2+ Imaging
2.8.1 Live Ca2+ Imaging
For Ca2+ imaging, we used Fluo-3 acetoxymethylester (Fluo-3, AM, C51H50Cl2N2O23, MW-
1129.86, 50 g package, Invitrogen, F-1242) as a Ca2+ indicator. DIV 10-12 cultured mouse hip-
pocampal neurons (uninfected or infected on DIV 4) grown on glass coverslip (Roth) were loaded
with Fluo-3 at a concentration of about 3 M in CO2 independent SGG for 20 min at room tem-
perature. Then the coverslip was washed with fresh SGG and then transferred to a custom made
chamber with fresh SGG, sitting at room temperature for 20 to 30 min for AM digestion. Calcium
imaging was carried out with Leica SP2 confocal microscope. The setting up was as follows: 40x
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objective/NA1.25 oil, Zoom 1, 512 x 512 format, 8 bit resolution, xyt scan mode, 400 Hz speed, 1.0
airy pinhole, frame average 1, line average 4 for image, and 1 for time lapse imaging. Virus infected
cells were excited with 594 nm laser at 10 30% to see the red fluorescence from mCherry and 30%
488 nm laser for the Ca2+ indicator Fluo-3. Emission fluorescence was collected at 600 650 nm
for mCherry and 500 550nm for Fluo-3. Time lapse imaging was set with a ∆ T of 1.635 sec and
totally 200 frames were recorded at the basal Ca2+ level recording. Bic or CCh was introduced at
frame 120 (about time point 196 sec). To calibrate the fluorescence signal (F), Fluo-3 was saturated
by adding 50 µM ionomycin (Fmax, Sigma-Aldrich Chemie GmbH, München, Germany) to SGG
solution (containing 2 mM Ca2+) and then quenched with MnCl2 (Fmin). Ca
2+ concentration was
expressed as a function of the Fluo-3 fluorescence Kd * [(F-Fmin)/(Fmax-F)]. The Kd for Fluo-3
was 390 nM at room temperature according to the data sheet. After imaging, data were analyzed
offline with ImageJ software (NIH). For the virus infected groups, only mCherry positive cells were
analyzed and included in the presented results.
2.8.2 List of Ca2+ Indicators
In the study, list of Ca2+ sensors (Table 2.22) were used and they were purchased from Molecular
ProbesTM .
Table 2.22: Ca2+ Indicators
Indicator Kda Exb Emc Stock Working
(nM) (nm) (nm) (mM) (µM)
Fluo-3 325 506 526 1.46 3.8
Fura-2 140 335/363d 510 1 1
X-rhod-1 700 576 602 0.6 0.6
a Dissociation constant (Kd) were determined at 22 ◦C by
Molecular Probe
TM
in 100 mM KCl, 10 mM MOPS, pH 7.2 and
10 mM CaEGTA.
b The excitation wavelength used and it is the maximum
absorption wavelength.
c The maximum emission wavelength.
d Fura-2 is a ratiomatric Ca2+ sensor and two excitation
wavelengthes are used for measuring the free Ca2+ concentration.
All the Ca2+ indicators were in the form of AM (acetoxymethyl) ester. The AM esters were first
reconstituted in DMSO (di-methylsulfoxide) with 20% (w/v) non-ionic detergent Pluronic F-127
to a stock concentration and diluted to working concentration on use. After designed experimental
Ca2+ imaging, except for Fura-2, the maximum and minimal fluorescence (Fmax and Fmin) were
measured. Free Ca2+ concentration was calculated using the following equation:
Ca2+free = Kd ·
F− Fmin
Fmax − F (2.1)
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2.9 Electrophysiology
Whole-cell patch-clamp recordings were made at room temperature from cultured hippocampal
neurons plated on coverslips after a culturing period of 12 to 14 days. Coverslips were secured
with a platinum ring in a recording chamber (Open Access Chamber-1, Science Products GmbH)
mounted on a fixed-stage upright microscope (BX51WI, Olympus). Differential interference con-
trast optics, infrared illumination, and a Neo sCMOS camera (ANDORTM Technology) connected
to a contrast enhancement unit (Argus, Hamamatsu) and Andor iQ2 sofeware were used to view
neurons on a video monitor. Recordings were made with a Multiclamp 700A amplifier, digitized
through a Digidata 1322A A/D converter (Axon Instruments), and acquired by using Clampx 10.3
software (Molecular Devices). All membrane potentials were corrected for the calculated junction
potential of -11 mV (JPCalc program by Dr. Peter H. Barry). Patch electrodes (World Precision
Instrument, Glass thin wall filament 3IN, TW150F-3, 0.1F s/n) were made from a single stage
glass microelectrode puller (Model PP-830, Narishige). The settings for the puller were: heat 1,
78.2◦C and heat 2, 49◦C. Glass pipette capacitance filled with internal solution in aCSF was 3.5 to
4.5 MΩ.
2.9.1 Extracellular Solution & Drugs
Standard aCSF (artificial Cerebrospinal Fluid) was used as extracellular solution for electrophysi-
ological recording. The composition of the aCSF was as in Table 2.23. Osmolarity was measured
with a osmometer VAPRO R©5520 (Viescor). After preparation, the aCSF was saturated with carbo-
gen (95% oxygen and 5% carbon dioxide) bubbling for 20 min. Cells were recorded with constant
aCSF perfusion.
Table 2.23: Artificial Cerebrospinal Fluid (aCSF)
Component Concentration M.W. 10x Stock Osmoliarity
(mM) (g/mol) (g/l) (mOsm)
NaCl 125 58.44 73.05 250
KCl 3.5 74.54 2.61 7
CaCl2 · 2 H2O 2.4 147.02 3.53 7.2
MgCl2 · 6 H2O 1.3 203.03 2.64 3.9
NaH2PO4 · H2O 1.2 137.99 1.66 2.4
Glucose · H2O 10 198.17 10
NaHCO3 26 84.01 52
Sum 332.5
Glucose and NaHCO3 are added to the 1 liter of 1x aCSF freshly with the amount
of 1.98 g and 2.18 g , respectively.
Pharmacological drugs used during the electrophysiological recording were prepared as stock
solution and diluted into aCSF according to Table 2.24. So these drugs were applied as the perfusion
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system onto cells.
Table 2.24: Drugs
Drugs Concentration Stock Dilution
(µM) (mM)
TTX 0.5 1 1:2000
Gabazine 5 10 1:2000
Cyclothiazide 20 100 1:5000
AMPA 10 5 1:500
2.9.2 Internal Solution
Internal solution was prepared according to Table 2.25. It was used after filtration through a non-
sterile PVDF filter, 0.22 µm, 13 mm (Rotilabo R©-Spritzenfilter, Roth R©).
Table 2.25: Internal Solution
Componenta Concentration M.W. For 49.29 mlb Osmoliarity
(mM) (g/mol) (mg) (mOsm)
K+−methylsulfate 133 150.2 984.65 266
HEPES 10 238.3 117.46 10
NaCl 8 58.4 23.03 16
KCl 12 74.56 44.10 24
ATP−Mg2+ 4 507.18 100 8
GTP−3Na+ 0.5 523.18 12.89 2
Phosphocreatine−2K+ 10 287.3 141.61 30
Sum 326
a Each component should be dissolved individually to avoid any precipitation. Final pH value
should be between pH 7.35 and 7.45.
b This is the final volume for using a whole bottle of ATP−Mg2+ containing 100 mg of it.
2.9.3 Blue Light Stimulation
For simultaneous patch recording and ChR2 activation, the blue light from a 470 nm LED through
the objective was controlled by Clampx 10.3 software with digital output. The protocol used were
either single flash (10 ms duration) or flashes in bursts (10 ms pulse duration at 20 Hz for 1 sec).
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2.9.4 Mini Recording
Miniature excitatory postsynaptic currents (mEPSCs) were recorded in the presence of TTX (1 µM,
Biotrend, Cologne, Germany). All voltage clamp recordings were performed at a holding potential
of -70 mV. mEPSC events were detected using the software MiniAnalysis (Synaptosoft) with a 5
pA amplitude threshold and all mEPSCs were proof-verified manually. Access resistance (Ra) and
membrane resistance were regularly monitored during voltage clamp recording to be in the range
of 10 - 28 and 150 - 650 MΩ, respectively. If changes larger than 30% occurred, the data was
rejected from analysis. Cumulative probability curve was generated from more than 300 mEPSCs.
Mean values for mEPSC parameters between groups were analyzed using ANOVA and a post-hoc
Turkey’s test. All results presented were as mean ± s.e.m.
2.10 Cellular Compartment Analysis of Temporal Activity by
Fluorescence In Situ Hybridization (catFISH)
Expression of immediate early genes (IEG) is induced in brain neurons by synaptic activity and is
frequently used to monitor neuronal activation. Cellular compartment analysis of temporal antivity
by fluorescence in situ hybridization (catFISH) uses fluorescence in situ hybridization (FISH) of
IEG RNAs to fixed cultured neurons, and confocal microscope to identify the activity requirement
for IEG transcription initiation. The temporal resolution properties of catFISH derive from the
time course of IEG transcriptional activation (and subsequent termination) and the translocation
of the nascent mRNA to the cytoplasm. Cells active shortly before fixation ( 2 to 15 min) are
distinguished by the presence of one or two areas of intense intranuclear fluorescence; these foci
typically disappear within 20 min and the mRNA becomes prominent within the cytoplasm. This
cytoplasmic RNA signal is used to identify neurons active 30 to 45 min earlier. Thus, the sub-
cellular location of an IEG RNA signal can be used to discriminate cells activated by two distinct
experiences separated by 30 min.
Activation of mouse IEG Arc was examined in this study. The plasmid pBSII(SK)-mArc was
from Paul F. Worley lab (Johns Hopkins University, School of Medicine, Baltimore, Maryland).
The protocol was based on the "catFISH, Neuroanatomical Methods, Current Protocols in Neuro-
science" [54], with minor modification.
2.10.1 Plasmid Linearization and Purification
The template plasmid, pBluescript II SK (+)-Arc (pBSII(SK)-Arc)had cDNA for mouse or rat Arc
gene between EcRI and XhoI restriction sites. This plasmid had T3 and T7 RNA polymerase
promoter sequences at the two sides of Arc gene (Figure 2.3). Riboprobes were generated from
linearized plasmids by in vitro transcription using fluorescein-labeled dUTPs. So the combination
of EcoRI digestion and T7 polymerase transcription would produce the antisense probe. Similarly,
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XhoI digestion and T3 polymerase transcription would produce the sense probe.
pBSII SK (+)-
Arc
EcoRI XhoIArc cDNA
~ 3kb
T
3 T
7
Figure 2.3: Arc cDNA in pBSII SK(+) vector. Coding sequence of Arc gene was cloned in pBluescript SII
SK(+) vector flanked with EcoRI and XhoI restriction sites and T3 and T7 RNA polymerase
promoters at each end (from Paul F. Worley, Johns Hopkins University,Baltimore). Restriction
enzyme digestion and RNA polymerase are used for in vitro synthesis of RNA: EcoRI digested
plasmid followed with T7 RNA polymerase in vitro transcription produce the anti-sense RNA
probe against Arc mRNA; XhoI digestion and T3 RNA polymerase transcription make the sense
RNA probe.
4.5 µg of the template DNA was digested with EcoRI and XhoI, respectively. An example
digestion setup was shown in Table 2.26.
After the digestion, linearization result was tested by running a 1% agrose gel together with the
non-digested plasmid. The rest of the linearization product was purified with Phenol/Chloroform
method. The cut constructs were filled up to 200 µl with DEPC-treated H2O and the same volume
(200 µl) of Phenol/Chloroform buffer (Tris-buffered 50% phenol, 48% chloroform, 2% isoamyl
alcohol solution, so called "25:24:1" solution) was added in. The mixture was mixed with vortex
and centrifuged with speed 1300 g at room temperature for 10 min. The supernatant was transferred
to a new RNase free tube and the 25:24:1 solution treatment was repeated once again. About 200
µl (as much as possible) supernatant was collected and mixed with same volume of Chloroform.
The solution was mixed with vortex and centrifuged at 1300 g, room temperature for 10 min. The
supernatant after Chloroform treatment was mixed with 1 µl of glycogen (20mg/ml), 0.1 volume of
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Table 2.26: DNA Linearization
Component 60 µl Reaction
(µl)
DNA 45a
Red Buffer (10x) 6
Enzymeb 2
H2O up to 60 µl
a DNA concentration was adjusted to 100
ng/µl.
b EcoRI and XhoI digestion were made
separately and parallely.
3 M Na-acetate and 2.5 volumes of absolute ethanol. This mixture was put on dry ice for the DNA
to precipitate for 10 to 15 min. After a few seconds of warm up, it was spun down in a 4◦C cooled
centrifuge at 1400 g for 20 min. This time, the supernatant was discarded and the pellet was washed
with 650 µl 70% ethanol twice, both with centrifugation at 4◦C , 1400 g for 10 min. The pellet
was dried up at room temperature and resuspended with 25 µl DEPC-treated H2O. Concentration
of the purified DNA probe was measured with a photometer (Pharmacia Biotech Ultraspec 2000
Spectrophotometer).
2.10.2 RNA Probes
For the in vitro transcription, SP6/T7 Transcription Kit (DIG RNA Labeling Kit (SP6/T7), Roche
11175025910) and T3 polymerase (Roche 11031163001) were used to get the antisense and sense
RNA probe for Arc gene. The procedure was as follows.
Step 1 1 µg purified template DNA or 4 µl control DNA (vial 3 or 4) and DEPC-treated
H2O was added into a RNase-free tube to the final volume of 13 µl.
Step 2 Following reaction mix (Table 2.27) was prepared on ice.
Table 2.27: In vitro Transcription
Reagent Vial Volume (µl)
NTP labeling mixture, 10x 7 2
Transcription buffer, 10x 8 2
RNase inhibitor 10 1
RNA Polymerase T7 or T3a 12 2
a T3 RNA polymerase was purchased separately.
The mixture was mixed gently and briefly spun down.
The tube was incubated at 37 ◦C for 2 h to do the in vitro transcription.
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Step 3 After the transcription, 2 µl DNase I, RNase-free was added to remove template
DNA.
This was incubated at 37◦C for 15 min.
Step 4 The whole reaction was stopped with adding 2 µl 0.2M EGTA (pH 8.0).
After in vitro transcription, the products were purified further with columns and the final RNA
probe concentration was measured.
2.10.3 Fixation and Prehybridization
After different treatments, cells were fixed with ice-cold 4% PFA (pH 7.2 to pH 7.6) for 10 min.
The fixation, following washing and prehybridization steps were summarized in Table 2.28.
Table 2.28: catFISH-Fixation & Prehybridization
Procedure Solution Time (min)
Incubation 4% PFA,ice-cold 10
1x PBS 2
1x PBS 2
70% EtOH 1
95% EtOHa 1
Rinse 2x SSCb 2
Incubation Acetic anhydride solution 10
Rinse DEPC-H2O several times
Incubation 1:1 acetone/methanol solution, ice-cold 5
Rinse 2x SSC 5
Incubation 1x Prehybridization solution 30
a Point to stop. Coverslips could be stored in 95% EtOH for several days.
b SSC: saline-sodium citrate buffer.
For the prehybridization, 1x prehybridization solution (Sigma P1415, 2x concentrate. Diluted
1:1 with deionized Formamide to prepare 1x pre-hybridization solution immediately before use.)
was applied to each coverslip on parafilm in the chamber. Some Whatman 3 MM filter paper was
saturated with 2x SSC / 50% deionized formamide and put at the bottom of the chamber. Cover-
slips were incubated in this humid chamber for 30 min at room temperature.
2.10.4 Hybridization
After the prehybridization, coverslips were rinsed in 2x SSC. A final concentration of 1 ng/µl RNA
probe (both antisense and sense, separately) were prepared in 1x hybridization solution (Sigma
H7140, 2x concentrate. Diluted 1:1 with deionized Formamide to prepare 1x hybridization solution
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immediately before use.). The probe was denatured by being heated for 5 min at 90 ◦C and
followed immediately by rapid cooling in an ice bath. Hybridization was performed in the humid
chamber in a 56◦C oven overnight for at least 16 hours.
Following hybridization, coverslips were washed (Table 2.29) to remove unbound probe or probe
which had loosely bound to imperfectly matched sequences. During all the subsequent washing
steps, coverslips were gently agitated.
Table 2.29: Wash after Hybridization
Procedure Solution Time (min)
Wash 2x SSCa 5
2x SSC 5
2x SSC 5
Treatment 10 µg/ml RNasaeA in 2x SSC, 37◦C 15
Wash 2x SSC 10
Treatment 10 U/ml DNase Ib, 37◦C 15
Wash 2x SSC 10
0.5x SSC 10
0.5x SSC, 56◦C 30
0.5x SSC 10
Treatment 2% H2O2 in 1x SSC 15
Wash 1x SSC 5
1x SSC 5
1x SSC 5
TBS 5
a At room temperature if not stated.
b DNaseI treatment is needed for transfected or infected conditions only.
2.10.5 Signal Detection
FISH signals were detected with horseradish peroxidase (HRP) conjugated antibody to digoxi-
genin and amplified using a Cyanine-3 Tyramide Signal Amplification kit ( TSA kit, PerkinElmer,
NEL704A). Briefly, coverslips were blocked with TNB blocking buffer (0.1 M Tris-HCl, pH
7.5; 0.15 M NaCl; 0.5% Blocking reagent supplied by the TSA kit) at room temperature for 30
min. HRP conjugated DIG antibody (Anti-Digoxigenin-POD, Fab fragments from sheep, Roche
11207733910) was applied to coverslips at 1:100 dilution, 4 ◦C overnight. On the next day, cov-
erslips were washed three times with TNT wash buffer (0.1 M Tris-HCl, pH 7.5; 0.15 M NaCl;
0.05% Tween 20) at room temperature with 5 min interval. Coverslips were then incubated with
Fluorophore Tyramide for 30 min at room temperature. Fluorophore Tyramide was 1:87.5 diluted
in Amplification Diluent. After three times wash with TNT wash buffer, coverslips were coun-
terstained with nuclear fluorescent Hoechst 33258 (Serva, 2 µg/ml in PBS) for 5 min at room
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temperature. Cells were then washed with PBS for three times with 5 min interval and mounted
with Mowiol.
2.10.6 Acquisition of Confocal Image Series
catFISH results were examined with Leica SP2 confocal microscope. The setting up for the con-
focal microscope was: 63x objective/Numerical aperture 1.32 oil, Zoom 2, 1024 x 1024 format, 8
bit resolution, xyz scan mode, 400 Hz speed, 1.0 airy pinhole, line average 2, frame average 1. Z
dimension depth was defined with the Cy-3 signal and normally it spanned 7 to 10 µm. Intensity
settings of photomultiplier tubes (PTM) for Hoechst and Cy-3 were set to get the minimal signal
but not saturated for the highest. Signals from catFISH and Hoechst staining were scanned sequen-
tially between frames with a ∆Z of 1 µm. For the quantitative analysis, confocal settings was adjust
from above with the changes in: 40x objective, Zoom 1, 512 x 512 format, line average 1, and ∆Z
3 µm. These images were merged to get the maximal signal with ImageJ software and analyzed
for positive Arc signal or signal location.
2.11 Data Analysis
All the imaging data were analyzed off-line with ImageJ [117] and Microsoft ExcelTM (2010).
Graphs were made with SigmaPlotTM or GraphPad Prism R©. Images and graphs were processed and
organized in Inkscape [69]. References were managed through JabRef [71]. Statistic analysis was
performed with two-tailed homoscedastic Student’s T test (n.s.: not significant; *: p < 0.05; **:
p < 0.01; ***: p < 0.001).
Chapter 3
Results
Neuronal activity plays a critical role in neural development, in neural circuits formation and main-
tenance, and in learning and memory [32]. The regulation of gene transcription by neuronal ac-
tivity is an integral part of the process that underlies learning and memory [40]. Electrical ac-
tivation of neurons induces transient increases in the intracellular calcium (Ca2+) concentration,
which can propagate to the nucleus thereby linking synaptic stimulation to gene regulatory events
[11]. However, it is unclear if and how different spatial-temporal patterns of activity give rise
to distinct genomic responses. The first aim of my thesis was to use optogenetic methods to in-
vestigate activity dependent regulation of signaling pathways and gene expression in hippocampal
neurons. Specifically, I expressed Channelrhodopsin (ChR2), a light-gated, cation-selective, small
membrane channel in primary hippocampal neurons. ChR2 is a ion channel isolated from Chlamy-
domonas reidhardtii [99]. It is a nonselective cation channel with intrinsic light sensitivity and
is widely used in the field of neuroscience research [118, 83, 48]. It is fully functional when ex-
pressed in the mammalian system without addition of a cofactor. ChR2 can be activated with blue
LED pulses to reliably induce action potential firing.
I made a double mutant of ChR2 [154], C128A and T159C, termed ChR2-ab, which had a
longer opening time and larger ion conductance compared to the wild type. Transfection or recom-
binant adeno-associated virus (rAAV)-mediated gene transfer were used to express ChR2-ab in
cultured hippocampal neurons. Action potential bursts and associated Ca2+ transients were induced
with bursts of blue light. The expression of immediately early genes, including many well-known
activity regulated genes are robustly induced with specific blue light stimulation pattern in the
ChR2-ab expression cells. The mechanism underlying ChR2-ab function was analyzed.
The second aim of my thesis was to target ChR2 onto the internal membrane system in order to
directly evoke Ca2+ release from internal stores. Different endoplasmic reticulum (ER) and inner
nuclear membrane (INM) targeting sequences were used and the subcellular location of ChR2
was imaged with high-resolution microscopy. Ca2+ imaging and electrophysiological recordings
suggested that with ER and INM targeting sequences, ChR2 was localized away from the plasma
membrane.
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The regulation of gene transcription by neuronal activity is an integral part of the processes
underlying learning and memory. The third aim of my thesis was to determine what is the minimal
activity requirement for transcription initiation. To these ends, I used Bicuculline (Bic)-mediated
stimulation of neuronal activity to analyze the minimal activity required for Arc transcription initi-
ation. Arc was chosen as the model gene and catFISH was applied as the most sensitive method to
detect the first transcripts of Arc mRNA, and detailed Ca2+ imaging was utilized to detect nuclear
Ca2+ transients. Based on my data, I conclude that one nuclear Ca2+ transient is sufficient to initiate
Arc gene transcription.
3.1 Manipulation of Neuronal Activity with ChR2
In the central nervous system, maintenance and upregulation of activity induces synaptogenesis,
promotes dendritic morphogenesis, protects neurons and can enhance cognitive functioning. A de-
crease in or loss of neuronal activity leads to synapse loss, neuronal degeneration and malfunction
of the whole system. One means by which activity regulates neuronal function is through activity
regulated gene expression. Afferent stimuli trigger the release of neurotransmitter, which is sensed
by the receptors or channels on the target cell’s membrane. These signals are then transformed
within the cells via intracellular signal transduction pathways. One of the most important sec-
ond messengers in neurons is Ca2+. Ca2+ transients occur at the plasma membrane where NMDA
receptors and voltage-gated Ca2+ channels are activated and at the ER membrane when Ca2+ is
released from intracellular stores. Ca2+ entering the cell by these means invades nuclei, where it
can activate nuclear calcium signaling and lead to activity induced gene transcription. This can
happen when nuclear Ca2+ binds to CaM, forming the Ca2+/CaM complex, and the complex acti-
vates calcium/calmodulin-dependent protein kinase type IV (CaMKIV). CaMKIV phosphorylates
CREB at Ser133 site, which then binds to its transcriptional co-activator CBP and initiates gene
transcription. Here, ChR2-ab was used as a tool to induce neuronal activity. Activity dependent
gene expression was triggered by ChR2-ab activation, ChR2-ab and the underlying mechanisms
were analyzed.
3.1.1 Neuroprotective Effects of Synaptic Activity
Enhancing neuronal activity protects neurons against deleterious insults. For this work, I first
confirmed the neuroprotective effect of electrical activity induced by Bicuculline (Bic), a com-
petitive antagonist of GABAA receptors (γ-aminobutyric acid receptor, type A), in our cultured
hippocampal neurons. As our hippocampal cultures contained about 10% inhibitory interneurons
that imposed a tonic inhibition on the neuronal network, removal of GABAAergic inhibition with
Bic led the neurons to fire synchronous bursts of action potentials. The Bic-induced bursts of ac-
tion potentials occurred periodically and were associated with global calcium transients (Figures
3.1 A and B). Synaptic stimulation of cultured neurons induced gene expression and protected them
against NMDA-mediated excitotoxicity. Here, neurons stimulated with Bic for different periods of
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Figure 3.1: Bic treatment produces synaptic activation and protects neurons against deleterious challenge.
(A) Electrophysiological recordings of current-clamped neurons treated with 750 µM Bic.
Bursts of action potentials were recorded and the inserted trace amplifies a signal burst. (B)
Imaging of global Ca2+ transients in hippocampal neurons in basal condition and exposure to
Bic at marked point (blue arrow). (C) Immunocytochemistry analysis of cFos protein level be-
fore (Control) and different time periods of time after Bic stimulated (10 min, 30 min and 1
hour). C-fos level is represented with the staining intensity in arbitrary unit (a.u.). (D) Quanti-
tative analysis of a cell death experiment induced by NMDA bath application ( 20 mM, 10 min)
with and without Bic pre-treatment ( 50 µM, overnight). Data are represented as mean ± s.d. (n
= 3 independent cell preparations).
time (10 min, 20 min and 1 hour) expressed increasing levels of cFos, a cellular proto-oncogene
belonging to the IEG family of transcription factors (Figure 3.1 C).To verify the protective effect
of activity, neurons were challenged with bath-applied NMDA (20 µM NMDA for 10 min), which
led to around 60% cell death after 24 hours while the basal cell death rate was below 20%. Cells
pre-treated with Bic overnight were more resistant to this deleterious insult (Figure 3.1 D).
3.1.2 ChR2 Induced Activity in Cultured Hippocampal Neurons
Wildtype (wt) ChR2 was used to set up all the stimulation, recording, and subsequent functional
analysis used to investigate the possible activity induction function of ChR2 in neuronal cells. Hip-
pocampal neurons were transfected with mCherry-tagged ChR2, and electrophysiological record-
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Figure 3.2: ChR2 expressing neurons show blue light specific inward current and action potential. (A)
shows a neuron transfected with mCherry-tagged ChR2. (B) and (C) are the infra-red differential
interference contrast (IF-DIC) pictures of the same field with pipette patching to the mCherry
positive (B) and negative control cells (C). Arrows point to the tip of pipette. The scale bar
represents 50 µm. (D) is the result of voltage-clamp showing current change of the negative cell
(black line) and positive neuron (grey line) to blue light flash (blue bar). (E) represents voltage
changes of the ChR2 expressing neuron to a burst of blue light flashes at 1 Hz with flash duration
of 10 ms. (F) shows the current response of ChR2 positive neuron to low frequency (1 Hz with
duration of 10 ms) of flashes and high frequency of light bursts (10 Hz with 10 ms duration for
8 sec). Blue bars indicate flashes, not time scaled.
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ings were used to measure the light-induced currents triggered after 48 hours of expression. As a
membrane protein, ChR2 distributes well all over the neurons, including the dendrites, and forms
puncta at some branching points. Stimulation using the blue light evoked large inward currents in
ChR2-expressing cells (Figure 3.2). Control cells exhibited no response to blue light as shown by
the black line in (D). Neurons expressing ChR2 fired reliable action potentials to 1 Hz blue flashes
for a prolonged time as shown in (E). When the flash frequency was increased, however, cells failed
to resolve it, and instead exhibited a sustained negative current. I next examined the Ca2+ transients
triggered by ChR2-induced activity. As the blue light used to visualize fluo-based small molecule
Ca2+ probe activates ChR2, I chose to use Fura-2 and X-rhod-1 as calcium sensors. Fura-2 is a
ratiometric calcium dye with excitation peaks at 340 and 380 nm. Because 380 nm is strong and
closer to 470 nm (to activate the ChR2), I first did single-wavelength imaging using 340 nm. Ca2+
transients were indeed detected in concert with light flashes, but, as shown in Figure 3.3 (D), the
amplitudes were very small. I next performed the imaging with 380 nm excitation. Fluorescence
changes detected under these conditions were much larger than those observed with 340 nm. How-
ever, as the electrophysiological recordings shown in Figure 4.1 demonstrate, 380 nm light- and,
to a lesser extend-340 nm light activated ChR2. Therefore I elected to use X-rhod-1 to detect Ca2+
changes as the activation light for X-rhod-1 (560-580 nm) did not appreciably activate ChR2 (data
not shown). In this case, use of an mCherry tag would not be appropriate as its excitation spectrum
lies within the band of wavelengths used to excite X-rhod-1. I therefore removed the mCherry tag
from the original ChR2 construct and performed the Ca2+ imaging blindly. Figure 3.3 (F) shows the
Ca2+ transients evoked by blue flashes in one representative neuron. Although the calcium imag-
ing with ChR2 was not very successful, it was clear that activation of ChR2 did induce calcium
transients. I therefore moved on to analyze the cellular functions of ChR2 activation in neurons.
3.1.3 Characterization of Different ChR2 Mutants
After the first identification of ChR2 and application into neuroscience research, the coding se-
quence of ChR2 was optimized to the human codon for better expression in human systems. I
tested both the original algal sequence and the human codon optimized sequence, and did not ob-
serve any differences in expression. After some discussion with other labs, I decided to use the
original ChR2 coding sequence.During the evolution of optogenetic methods, many mutations of
ChR2 having different properties were developed. Two of them drew our interest. One was ChR2-
C128A, also called step-function opsin (SFO) or bi-stable ChR2 [13]. The cysteine at residue 128
is mutated to alanine. It is called ChR2-a in this study and it has a longer opening time than the
unmutated ChR2. ChR2-a can be activated with blue light and inactivated with green light, and
is as such bi-stable. The other ChR2 mutant that drew our interest was ChR2-T159C, which we
call ChR2-b. ChR2-b harbors a threonine to cysteine mutation at residue 159. ChR2-b is a high-
efficiency channelrhodopsin and can mediate fast neuronal stimulation at low light levels [12]. In
order to induce gene expression, we thought that a combination of these two mutants could make a
cell-depolarizing tool (ChR2-ab). Figure 3.4 shows that all three mutants expressed well in neurons.
Cultured hippocampal neurons were infected on DIV 4 and were fixed on DIV 11.
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Figure 3.3: ChR2 activation causes Ca2+ transients in neurons. (A) shows the mCherry channel representing
the infected neurons. (B) is the picture after Fura-2 loading taking with 380 nm excitation
wavelength. (C) is infra-red differential interference contrast (IR-DIC) image of the cells in the
same field. (D) and (E) are recording results from Fura-2 Ca2+ imaging made with 340 nm and
380 nm excitation, respectively. Note the different scale of Y-axis. (F) shows the X-rhod-1
imaging result. Grey lines are uninfected neurons and colored lines represent ChR2 expressing
cells. The scale bar is 50 µm.
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Figure 3.4: AAV mediated expression of different ChR2 mutants. Two single mutants, ChR2-a (C128A)
and ChR2-b (T159C), and a double mutant, ChR2-ab (C128A+T159C), are shown. mCherry
channel is the fluorescent tag showing the distribution of ChR2. Hoechst is the nucleus counter
staining. The scale bar represents 50 µm.
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3.1.4 Gene Induction Elicited by ChR2-ab
To investigate the potential cellular function of ChR2s, I performed quantitative PCR (Q-PCR) to
analyze the expression level of activity regulated genes upon light-mediated activation of cultured
neurons. For this experiment, neurons were infected with rAAV viruses carrying different versions
of mCherry-tagged ChR2 coding sequences. Infection was chosen because the efficiency is much
higher than transfection; about 30% in rat culture and reaching 80 to 90 % of the cell population in
mouse culture. As a membrane protein, ChR2 needs a certain period of time to be expressed and
inserted into the cell membrane to function properly. For this experiment, we therefore used mouse
cultures and performed gene expression analysis nine to ten days after infection on DIV 13/14.
The expression level of nine activity-regulated inhibitor of death (AID) genes [157] was analyzed
in cells infected with ChR2-a, -b and -ab mutants stimulated with blue light for four hours. As
shown in Figure 3.5, only ChR2-ab infected neurons responded. The raw data of 6 representative
genes (gene level with and without LED light stimulation) show that expression is only induced
in cells infected with ChR2-ab mutant (Figure 3.5 A-F). This result can be clearly seen when the
light-stimulated gene expression levels are normalized to unstimulated gene expression levels from
the same group of cultures (Figure 3.5 G). Except for btg2, which is induced with fast kinetics
after AP bursting and peaks at 2 h instead of 4 h [157], all genes are significantly and specifically
up-regulated in ChR2-ab infected cells with blue light stimulation.
Because of this obvious phenomenon of ChR2-ab, I then focused on verifying its function and
the underlying mechanism.
3.1.5 Mechanism of ChR2-ab Function
Induced expression of the nine analyzed activity-dependent genes in ChR2-ab expressing neurons
strongly suggested that artificial activity could be applied to neurons in a controlled manner and
this exogenously introduced activity initiated endogenous cellular responses. But the underlying
mechanism was still not clear. The next questions we asked were how ChR2-ab-mediated activity
was transduced into cells, and which effectors were involved in the gene induction process. Phar-
macological methods were used to identify whether other receptors or channels were involved in
the function of ChR2-ab.
To investigate the involvement of NMDA receptors, AMPA receptors, L-type voltage depen-
dent calcium channels (VDCC), and sodium channels, I treated hippocampal neurons with 10 µM
MK801 plus 50 µM APV, 20 µM DNQX, 10 µM Nifedipine, and 1 µM TTX, respectively, for 30
minutes prior to and during stimulation with blue light. As shown in Figure 3.6, the induction was
completely blocked when L-type VDCCs were inhibited. Unexpectedly, DNQX treatment resulted
in the induction of some AID genes under basal conditions. This effect was enhanced the cells
were stimulated with blue light. A similar effect has been reported for BDNF-mediated activity
[113]. In particular, the BDNF-induced expression of Arc was enhanced in the presence of NBQX,
another AMPA receptor blocker. Because of the effect of DNQX on basal gene expression, AMPA
receptor involvement was not further analyzed in ChR2-ab function. From the normalized gene
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Figure 3.5: Gene level analysis of activity-regulated inhibitor of death (AID) genes with Q-PCR on control,
ChR2-a infected, ChR2-b infected and ChR2-ab infected neurons. (A) to (F) Q-PCR analysis of
relative gene expression of six representative genes in un-infected, ChR2-a-mCh, ChR2-b-mCh
and ChR2-ab-mCh infected cultures (no inf., a, b and ab, respectively) with (colored bars) and
without (blank bars) blue light treatment from one representative experiment. (G) Ratiomatric
analysis of 9 AID gene expression level between LED light stimulated and non-treatment con-
ditions with the respective infection. Dotted line marks no gene induction (1 fold). Except for
btg2, all other 8 genes in "ab infected" group were significantly higher than control. Data are
represented as mean ± s.d. (n = 3 independent cell preparations).
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Figure 3.6: ChR2-mediated gene induction is mainly dependent on L-type VDCC. (A) to (E) are Q-PCR
analysis results showing raw data of relative gene levels of gadd45β, gadd45γ, ifi202b, inhba
and npas4 in control (ctrl.) and ChR2-ab infected (ab) cells with and without LED stimulation
in the absence and presence of 10 µM nifedipine (nif.), 10 µM MK801 + 50 µM APV (mk/apv)
and 20 µM DNQX (dnqx) of one representative experiment. Blank bars represent no light stim-
ulation and colored bars are with LED treatment for 4 hours. (F) is Q-PCR results showing the
level of the same 5 genes in the basal condition without LED treatment but in the presence of
nifedipine, MK801+APV, TTX (1 µM, ttx) and DNQX in control cells after 4.5 hours treatment
(0.5 hour pretreatment). Note that DNQX treatment itself already potentiates gene expression.
(G) is normalized Q-PCR results of activity-regulated inhibitor of death (AID) genes between
light stimulated ChR2-ab infected neurons with and without blocker pretreatment. Dotted line
marks no gene induction (1 fold). Data are presented as mean ± s.d. and n=3.
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expression analysis, ChR2-mediated, light-induced expression of atf3, inhba and serpinb2 were
L-type VDCC, NMDA receptor, and sodium channel dependent. As mentioned above, four hour
stimulation was not the optimal time point for analyzing the induction level of btg2, and it did not
show any dependency on any receptor/channel here. Except for btg2, ChR2-ab mediated induc-
tion of all other 8 AID genes was significantly inhibited when L-type VDCCs were blocked with
Nifedipine. Excepting gadd45β and gadd45γ, AID gene induction was also blocked by pharma-
cological antagonism of NMDA receptors or sodium channels. These results indicate that L-type
VDCCs play an essential role in ChR2-ab mediated gene induction.
Previous data have shown that nuclear calcium plays a particularly important role in activity-
dependent transcription. To investigate the potential role of nuclear calcium signaling in ChR2-
ab-mediated gene transcription, calmodulin binding protein 4 (CaMBP4) was used to inhibit nu-
clear calcium function. CaMBP4 is a nuclearly localized protein that contains four repeats of the
M13 calmodulin binding peptide derived from the rabbit skeletal muscle myosin light chain ki-
nase. It binds to and inactivates the nuclear calcium/calmodulin (Ca2+/CaM) complex [144]. As
shown in Figure 3.7 A, four example genes (arc, bdnf, c-fos and inhba) whose expression are
dependent on nuclear calcium signaling [156], were induced with LED light stimulation in ChR2-
ab-infected neurons. This induction was blocked when the cells were co-infected with viruses
harboring CaMBP4. The gene induction levels of nine AID genes were analyzed in this experi-
ment. In Figure 3.7 B, basal level 1.0 means CaMBP4 has no blocking effect and numbers smaller
than 1.0 mean that nuclear calcium function inhibition blocked the gene induction. In this case, all
nine AID genes show nuclear calcium dependency as the gene induction level after normalization
was lower than 1.0.
Given the importance of CREB and its co-activator CREB binding protein (CBP) in mediating
transcriptional activation by synaptic activity and nuclear calcium signaling, and in light of the crit-
ical role of CREB/CBP in neuronal survival, I next tested the role of CBP in ChR2-ab induced gene
expression. In these experiments, I used a protein called E1A to interfere with the function of CBP.
E1A is an adenovirus protein whose major role is to induce cell entry into the S phase of the cell
cycle. It thus provides an optimal environment for viral replication [100]. E1A achieves this effect
by interacting with a number of cellular proteins, including the CBP/p300 family of transcription
coactivators. E1A binds to CBP via its amino terminal-conserved region 1 (CR1) and disrupts its
function by competitively inhibiting the interaction between CBP and cellular transcription factors
[6]. As expected, rAVV-mediated expression of E1A blocked the ChR2-ab induced expression of
c-fos (Figure 3.8 B), a known target of the CREB/CBP transcription factor complex [28]. Expres-
sion of E1A also blocked the light-mediated induction of most AID genes. Expression of a mutant
version of E1A lacking the CR1 domain (E1A∆CR1) that fails to interact with CBP had no ef-
fect on bdnf, c-fos, gadd45β or inhba regulation. When these data examining the role CBP are
analyzed in the same way as were the data for CaMBP4, it can be clearly seen that E1A blocked
ChR2-ab-mediated, light-induced, expression of arc, bdnf, c-fos, gadd45β, gadd45γ, ifi202b, in-
hba and nr4a1. These results indicate that CBP plays an essential role in ChR2-ab-induced gene
induction.
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Figure 3.7: ChR2-ab mediated gene induction is dependent on nuclear Ca2+. (A) is four representative genes
showing the expression level (ratio between LED stimulated and non-treated conditions, led/non)
in no infected (no inf.), ChR2-ab infected (ab), CaMBP4 infected (cambp4) and double infected
with ChR2-ab and CaMBP4 (ab+cambp4) conditions of one representative experiment. Inset is
the same four genes induced with Bic stimulation for 4 hours and this Bic mediated gene induc-
tion is blocked when the cells are infected with CaMBP4. (B) is the normalized induction level
of 9 AID genes showing the effect of CaMBP4. A ratio of gene level between light stimulated
double infected (ChR2-ab and CaMBP4) and ChR2-ab single infected cultures is made and level
1.0 indicates the gene induction is not effected by CaMBP4. Light induced, ChR2-ab mediated
induction of all 9 AID genes are significantly inhibited by CaMBP4 expression (n=4).
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Figure 3.8: Disruption of CBP function inhibits light induced gene expression in ChR2-ab infected neurons.
(A) to (D) are Q-PCR analysis of four representative genes showing the raw data with and
without LED light stimulation for 4 hours. Cells were not infected (no inf.), infected with
viruses expressing ChR2-ab (ab), E1A (e1a), E1A∆CR1 (e1a∆cr1) and double infected. (E)
shows the effect of E1A on gene induction. Q-PCR analysis of 10 genes with double infection
are normalized to ChR2-ab single infection (n=3).
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3.1.6 Signaling pathways activated with ChR2-ab-mediated activity
I next investigated the signaling mechanisms through which ChR2-ab induces gene expression upon
light activation. Whole cell lysates from cultured hippocampal neurons infected with AAV-ChR2-
ab and stimulated with blue light were subjected to immunoblot analysis using antibodies specific
for phosphorylated-CREB (pCREB, at Ser133 site) and phosphorylated-ERK1/2 (pERK, dually
phosphorylated at Thr202 and Tyr204 of ERK1, Thr185 and Tyr187 of ERK2). To our surprise,
the basal levels of pCREB and pERK were elevated in ChR2-ab-expressing neurons and they were
reduced following 10 min light stimulation. In a control experiment, we found that light stimula-
tion did not affect CREB or ERK phosphorylation in uninfected neurons (Figure 3.9 A). Previous
work has shown that calcium entry through extrasynaptic NMDA receptors activates a general and
dominant CREB shut-off pathway [62]. I therefore used MK801 and APV to examine whether ex-
trasynaptic NMDA receptors mediated CREB shut-off was the case in ChR2-ab-expressing cells.
MK801 is a non-competitive and APV is a competitive antagonist of NMDA receptors. They were
used together to block both synaptic and extrasynaptic NMDA receptors. As shown in Figure 3.9
A, B and C, pre-incubation of neurons with MK/APV only partially blocked the decrease in CREB
phosphorylation upon LED stimulation. We therefore turned to another way of investigating the
involvement of extrasynaptic NMDA receptors in light-induced CREB de-phosphorylation: in un-
infected neurons, 50 mM KCl was used for 20 min to promote phosphorylation of CREB. When
NMDA was then bath applied for 10 min, pCREB level was reduced. Stimulation with blue light
mimicked the effect achieved with NMDA bath application; both NMDA treatment and light stim-
ulation resulted in decreased pCREB levels in ChR2-ab-infected cells. Any further treatment (KCl,
KCl+NMDA or KCl+LED) decreased pCREB level in ChR2-ab infected cells (3.9 D). These re-
sults indicate that light-induced, ChR2-ab-mediated CREB shut-off is achieved through activation
of extrasynaptic NMDA receptors.
3.1.7 Increased basal activity in ChR2-ab infected neurons
Network neuronal activity is critical for signal transduction and gene induction. To study the causal
element for elevated basal pCREB in ChR2-ab expressing neurons, I performed whole-cell patch
clamp recordings and measured the miniature excitatory postsynaptic currents (mEPSP). The par-
ticular aim of these experiments was to determine whether ChR2-ab infection had any effect on
the electrical properties of the neurons. As a control for potential artifacts resulting from the over-
expression of a membrane protein, ChR2-b was included in this experiment. As shown in Figure
3.10, ChR2-ab-infected neurons resulted in a markedly increased basal activity, which was evident
in the strongly decreased inter event interval (IEI). By contrast, expression of ChR2-b had no in-
fluence on the IEI (Figure 3.10 G). The membrane resistance of ChR2-ab infected neurons was
significantly lower than that measured in uninfected cells (Figure 3.10 D). This might be due to the
decreased IEI. Other electrical properties, including membrane capacitance (Cm), mEPSC rise time
and decay time, mEPSC amplitude, and access resistance (Ra) for patching were not different from
that measured in uninfected neurons. Furthermore, no difference was found between uninfected,
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Figure 3.9: Activation of CREB and ERK are elevated in ChR2-ab expressing neurons and light stimula-
tion decreases it. (A) is the western-blot analysis by using CREB and ERK phosphospecific
antibodies (pCREb and pERK) in uninfected (no inf.) or AAV-ChR2-ab infected (ChR2-ab
inf.) hippocampal neurons with and without LED light stimulation in the presence or absence of
10 µM MK801 and 50 µM APV. ERK is the internal protein level control for pERK. DsRed blots
mCherry tag to show the presence of ChR2-ab. Tubulin is used as loading control. (B) shows the
responses of control (un inf.) and ChR2-ab infected (ab) neurons to 20 µM NMDA (kcl+nmda)
and LED (kcl+led) with and without pretreatment with 50 mM KCl for 20 min (kcl).(C) and
(D) are quantitative analysis of pERK and pCREB levels. Blank bars present control condition
and blue bars are the LED stimulated ones. Data are presented as mean ± s.e.m. and n = 3
independent preparations.
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Figure 3.10: Patch-clamp analysis reveals that ChR2-ab expressing neurons show higher basal activity. (A)
is representative traces of mEPSC recording with un-infected and infected neurons with ChR2-
ab and ChR2-b. (B) to (H) are scatter plots showing the distribution and mean ± s.e.m. (hori-
zontal bars) of mEPSC amplitude (B), membrane capacitance (Cm) (C), membrane resistance
(Rm) (D), access resistance (Ra) (E), rise time of mEPSC (F), inter event interval of mEPSC
(I.E.I.) (G) and amplitude of AMPA responses (H). Data are presented as mean ± s.d.. Each
dot is one cell in one coverslip and 5 cell preparations are included.
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ChR2-b-infected, and ChR2-ab-infected neurons with regards to the total number of AMPA recep-
tors, which was measured via the amplitude of the depolarizing response to bath-applied AMPA
(Figure 3.10 H). These results indicate that the expression of ChR2-ab in neurons increases their
basal activity level without altering the number of AMPA receptors, quantal size or the gross mem-
brane properties.
3.1.8 ChR2-ab in cell death
Induction of the AID genes in ChR2-ab-expressing neurons strongly suggests its potential as a tool
to protect neurons from death. To investigate the role of light-induced activity in neuronal survival, I
carried out a cell death assay in which bath application of NMDA or staurosporine (STS) were used
to induce cell death in cultured hippocampal neurons. To our surprise, stimulation of ChR2-ab did
not show any protective effect, but instead induced massive cell death. I then turned to analyze the
basal cell death 20 hours after 4 hour LED activation on DIV 10 and DIV 14. As neurons developed
in vitro, the basal cell death rate increased, both in un-infected and in ChR2-ab-infected cultures
(Figure 3.11 E, compare DIV 10 and DIV 14 in control condition). On DIV 14, stimulation with
blue light led to significantly more cell death in ChR2-ab-infected than in control neurons. These
findings, together with our observations that ChR2-ab stimulation leads to CREB shut-off and an
increase in basal activity, led us to conclude that activating ChR2-ab in neurons partially activated
extrasynaptic NMDA receptors; and that this effect dominated the beneficial synaptic activation,
leading to cell death.
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Figure 3.11: LED induced cell death in ChR2-ab infected culture. (A) to (D) are pictures of Hoechst staining
from DIV 14 of non-infected (no inf.) and ChR2-ab infected (ab) cells with and without LED
stimulation. Concentrated and bright nuclei represent dead cells. (E) is the quantitative analysis
of cell mortality on both DIV 10 and 14 with blank bars for control and blue bars for LED
stimulated conditions. Data are presented as mean ± s.e.m. and from 4 independent cell
preparations. Scale bar is 50 µm.
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The nuclear Ca2+ pool can decode neuronal impulse patterns and may specify transcriptional re-
sponses. Buffering the nuclear Ca2+ by microinjecting BAPTA-D70 specifically reduced nuclear
Ca2+ rises induced by high KCl treatment and inhibited gene expression mediated by CREB [61].
However, whether nuclear Ca2+ itself is sufficient to activate CREB and induce gene transcription is
not yet clear. Recent reports show that the nuclear envelop (NE), which is contiguous with the ER
lumen, serves as a Ca2+ store, and that Ca2+ release can be induced from it [109]. To directly test
whether nuclear Ca2+ is sufficient to initiate gene transcription, we aimed at targeting ChR2 onto
the inner nuclear membrane (INM) in order to guide Ca2+ entry into nuclei from the ER. ChR2 is
Ca2+ permeable and when the driving force of Ca2+ is high enough, opening of INM-targeted ChR2
with light should induce Ca2+ transients in the nuclei.
3.2.1 Targeting sequences
ChR2 is a membrane protein harboring seven transmembrane domains and it has the amino-terminal
(N-) facing the extracellular space. According to its topology, ChR2 belongs to type IV-B class of
integral transmembrane proteins, which are multiple pass molecules and have their N-terminal do-
mains targeted to the ER lumen.
Table 3.1: ChR2 targeting sequences
Name Description Reference
(Non-targeted)
ChR2-mCh mCherry tagged ChR2
ChR2-eGFP eGFP tagged ChR2
ChR2A-tDimer cleavable tDimer [134]
(ER lumen comtrol)
ChR2-mCh-KDEL ER lumen targeting [135]
(ER-targeted)
ChR2-mCh-7aa KLRRRRI [94]
ChR2-mCh-6aa FLKKYL [152]
ChR2-mCh-36aa RKR motif from Kir6.2 [153]
(INM-targeted)
LBRN-ChR2-mCh Lamin-B receptor N-term [126]
ChR2-mCh-gB6aa DRLRHR [93]
ChR2-mCh-GNAEGR N-term of lamin C2 [5]
ChR2-mCh-AR∆11 AREG-cyto deleting last 11 aa [70]
ChR2-mCh-HB-EGF∆C 185-198 aa of human HB-EGF [64]
ChR2-LR2-215-h2nls-mCh long unfolded linker [92]
As the INM is continuous with ER membrane and the nuclear Ca2+ transients originate to a
large extent from the ER, I first tried using a number of different ER retention signals to target
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ChR2 onto the ER membrane. This strategy is based on the lateral diffusion of membrane proteins
between the ER and nuclear membranes. Once ER targeting was achieved, the second step would
be to trap ChR2 in the nuclear membrane. "KDEL," the classic sequence targeting proteins to the
ER, works perfectly with soluble proteins, but would not target a membrane protein to ER, so it
was used here as a control. For ER membrane targeting, three sequences rich in arginine or lysine
(R or K), which had been shown to have ER retention/retrieval functions, were attached to the C
terminus of ChR2-mCherry (Table 3.1). The localization of these targeted proteins was investigated
with spinning-disk confocal microscopy.
As there are no established INM targeting sequences, I tried several possible sequences for INM
targeting of ChR2. The Lamin-B receptor localizes to the inner membrane of the nuclear envelope
and anchors the lamina and the heterochromatin to the membrane. The N-terminal domain of the
Lamin-B receptor was found to function as a nuclear envelope targeting signal [126]. Amphireg-
ulin (AR; official symbol AREG) is synthesized as a type I transmembrane protein and is expressed
on the plasma membrane. Staining results, however, suggested that it translocated from the plasma
membrane to the ER or nuclear envelope. Its C-terminal lacking the last 11 residues, which ex-
posed the RKKL motif at the very C-terminal showed obvious nuclear envelope guidance function
[70]. Heparin-binding EGF-like growth factor (HB-EGF) is also synthesized as a type I transmem-
brane protein and is expressed on the cell surface. After exposure to ectodomain-shedding stimuli,
it translocates to the nuclear envelope. Studies show that a short sequence element within the cy-
toplasmic domain of HB-EGF (residue 185-198 of human HB-EGF) allows this transmembrane
protein to localize to the nuclear envelope [64]. Another study showed that a short sequence ele-
ment within the cytoplasmic tail of human cytomegalovirus glycoprotein B (DRLRHR, abbreviated
as gB-6aa here) was sufficient to induce translocation of the membrane protein CD8 to the INM
[93]. The unique N-terminal hexapeptide GNAEGR from meiotic lamin C2 was also shown to be
essential for nuclear envelope association [5].
ChR2-mCh ChR2-mCh-KDEL ChR2-mCh-6aa
A CB
Figure 3.12: Differently targeted ChR2 expressed in neurons. Maximal stacked spinning-disk confocal im-
ages of transfected neurons with wild type ChR2-mCh (A), ChR2-mCh tagged with ER lumen
targeting sequence KDEL (B) and ChR2-mCh tagged with lysine rich ER retention peptide
FLKKYL (6aa, C). Scale bar is 10 µm.
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The ER system in neurons extends into the dendrites, and it is difficult to exam the fine distribu-
tion of ChR2 (Figure 3.12). I thus used AtT20 cells, a cell line of mouse pituitary tumor, which is
flat and thus makes it easier to distinguish the plasma membrane from internal organs, and to exam
the distribution of targeted ChR2s. As shown in Figure 3.13, wild type ChR2 tagged with mCherry
or eGFP depicted the boundary of AtT20 cells with fine protrusions. As expected, the distribution
of ChR2-mCh-KDEL was similar to that of ChR2-mCh. ChR2A-tDimer harbors an auto-cleavable
peptide between ChR2 and the tDimer tag that becomes cleaved after translation. The soluble
tDimer showed a cytoplasmic fluorescence distribution. In contrast, ChR2-mCh-7aa/6aa showed
a distinct distribution, which was neither on the plasma membrane, like ChR2-mCh-KDEL, nor
in the cytosol, like ChR2A-tDimer. Mcherry signal from ChR2-mCh-7aa/6aa was excluded from
nuclei and exhibited a web-like distribution similar to that of the ER (ChR2-mCh-36aa showed a
localization similar to ChR2-mCh-7aa, and is not shown here).
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Figure 3.13: Differentially targeted ChR2s expressed in AtT 20 cells. Maximal stacked spinning-disk con-
focal images of wild type ChR2 tagged with mCherry (A), eGFP (B), cleavable 2A peptide
followed with tDimer (D), mCherry and KDEL sequence (E), arginine-rich peptide KLRRRRI
(7aa, C) and lysine-rich peptide FLKKYL (6aa, F). Scale bar is 10 µm.
The attempt to use INM targeting sequences was not successful. As shown in Figure 3.14,
LBRN and 6aa combination exhibited similar distributions to that achieved with 6aa alone, and
were mostly visible in the ER. All other sequences tested were found on the plasma membrane,
similar to the wild type ChR2.
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Figure 3.14: INM targeting sequences with ChR2-mCh expressed in AtT20 cells. Maximal stacked
spinning-disk confocal images of wild type ChR2-mCherry (A) and ChR2-mCherry followed
with AREG cytoplasmic domain without the last 11 residues (AR∆11, B), DRLRHR motif
from human cytomegalo-virus glycoprotein B (gB6aa, C), cytoplasmic segment of heparin-
binding EGF-like protein deleting the very C-terminal (HB-EGF∆C, D), N-terminal of Lam-
inB receptor followed by KDEL sequence (LBRN-KDEL, E) and FLKKYL (LBRN-6aa, F).
Scale bar is 10 µm.
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3.2.2 Characterization of targeted ChR2
Targeting of ChR2 to ER with the arginine and lysine rich sequence was promising from the image
results, and I continued to test their function with Ca2+ imaging and electrophysiological record-
ings. Fura-2 imaging results indicated that blue light stimulation of ER-targeted ChR2 did not
evoke any apparent cytoplasmic Ca2+ transients. Stimulation of wild-type ChR2-infected neurons,
on the other hand, reliably and reproducibly evoked cytoplasmic Ca2+ signals in time with the
stimulation (Figure 3.15 A and B). From voltage clamp recordings, I found that wild-type ChR2
and KDEL-tagged ChR2 exhibited similar inward currents in response to blue light stimulation,
and that these currents were remarkably decreased when ChR2 was targeted to ER with the 6aa
(FLKKYL) peptide (Figure 3.15 C).
ChR2-KDEL
Control
ChR2-6aa
ChR2-mCh
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C
Figure 3.15: ER targeted ChR2 does not induce Ca2+ transients upon light stimulation and mediates smaller
inward current. (A) is Fura-2 Ca2+ imaging with 380 nm excitation result of ChR2-mCh in-
fected coverslip. Blue line represents LED stimulation. Colored traces are mCherry positive
neurons and grey lines are negative ones. (B) is Fura-2 Ca2+ imaging result of ChR2-mCh-7aa
infected coverslip. Blue line represents LED stimulation. Colored traces are mCherry positive
neurons and grey lines are negative ones. (C) is recording of current with voltage-clamp from
control, ChR2-mCherry-6aa, ChR2-mCherry and ChR2-mCherry-KDEL infected neurons.
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3.3 Minimal Activity Requirement for Gene Transcription
To investigate the minimal activity requirement for gene transcription initiation, we chose the
widely studied arc gene, which plays a critical role in mediating the formation of long term memory,
as our model gene, and used Bicuculline (Bic) stimulation to induce neuronal activity in cultured
hippocampal neurons. This protocol uses a brief Bic treatment to produce synchronized bursts of
action potentials and then TTX, a sodium channel blocker, to stop bursting. To verify rapid arc
transcription, we used an RNA probe against mature arc mRNA and performed cellular compart-
ment analysis of temporal activity by fluorescent in situ hybridization (catFISH). CatFISH uses the
long RNA probe transcribed in vitro from the full length cDNA for the arc gene to detect mature
mRNA. In the first experiment, I stimulated mouse and rat hippocampal cells with Bic for 10 min,
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Figure 3.16: Electrical activation of neurons with Bic stimulation leads to arc transcription. (A) to (H) are
color merged maximal stacked confocal images of Hoechst staining (in blue) and Cy3 signals
from catFISH (in red). (A) to (D) are from mouse hippocampal neurons and (E) to (H) are
from rat hippocampal neurons. (A) is control condition without stimulation hybridized with
anti-sense probe against arc gene. (E) is from Bic treated for 20 min and hybridized with sense
arc probe. (B) and (F) are cells treated with Bic for 10 min, (C) and (G) for 20 min and (D)
and (H) for 1 hours. Scale bar represents 10 µm. (I) an (J) are quantitative results of scatter
graph (mean ± s.d.) showing percentage of counted nuclei positive for arc mRNA signal for
each time point from mouse and rat cultures, respectively.
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20 min and 1 hour, and fixed the cells immediately after these time points for in situ hybridization.
For 10 min Bic activation, arc mRNA was found only in nuclei in localized foci (Figure 3.16 B
and F for mouse and rat neurons, respectively). After 20 min of increased neuronal activity, arc
mRNA was transported into the cytosol and the hybridization signal appeared in the perinuclear
domain (Figure 3.16 C and G for mouse and rat neurons, respectively). With an activation longer
than 1 hour, arc mRNA diffused into the cytosol and dendrites (Figure 3.16 D and H for mouse
and rat neurons, respectively) and the signal was less localized than for brief stimulations. No
positive arc mRNA signal was detected for the unstimulated control condition and negative control
hybridized with sense probe (Figure 3.16 A and E). For quantitative analysis, arc mRNA signal was
categorized as present or absent, without taking into account the location of the signal. As shown
in Figure 3.16 I and J, for mouse culture and rat culture respectively, Bic progressively induced arc
gene transcription. Because rat cells were easier to obtain and generally had lower basal activity,
they were used for the subsequent studies (mouse cells: 10’: 24.97 ± 9.59%, mean ± s.d.; 20’:
50.35 ± 11.36%; 60’: 72.14 ± 6.01% and rat cells: 10’: 29.67 ± 4.48%; 20’: 41.85 ± 8.22%; 60’:
52.86 ± 4.88%).
Next, I shortened the time window for Bic treatment to investigate the relation between the
duration of activation and the levels of arc transcription. As a positive control, 10 min stimulation
was chosen because it gave clear discrete intranuclear foci of arc mRNA. As shown in Figure 3.17
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Figure 3.17: Bic stimulation for 10 seconds initiates arc transcription. (A) is catFISH result showing scatter
graph for percent of arc signal positive cells after different Bic stimulation periods. Bic-2’ and
Bic-5’ mean that cells were treated with Bic for 2 and 5 min respectively and fixed immediately
afterwards. Bic-2’+8’ and Bic-5’+5’ mean that cells were treated with Bic for 2 and 5 min,
respectively, and then TTX was put on for 8 and 5 min, respectively (to make a total of 10
min). Bic-10’ means cells were treated continuously for 10 min and fixed straight after it.
(B) is catFISH result of shorter Bic stimulation conditions. X-axis is the time periods for Bic
treatment. The middle five conditions were applied with TTX after Bic and fixed at 10 min
time point. Data are presented as mean ± s.d..
A, rat neurons were stimulated for 2 min, 5 min or 10min. Cells were either fixed immediately
after Bic treatment (Bic-2’ and Bic-5’) or 1 µM TTX was applied, and cells were fixed 10 min after
stimulation (Bic-2’+8’ and Bic-5’+5’). When cells were fixed immediately after 2 min or 5 min Bic
stimulation, arc mRNA positive cells were not significantly different from the control condition.
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For cells fixed 10 min after the start of stimulation, however, cultures stimulated with Bic for 10
sec, 20 sec, 30 sec and 1 min showed a similar proportion of positive cells (Figure 3.17 B). 2 min
stimulation plus 8 min TTX was not significantly different from 10 min Bic treatment. These data
indicate that arc gene transcription can be initiated by very brief stimuli.
Ca2+ transients are the effectors in the transmission of electrical stimulation to the nuclei to initi-
ate gene expression, which in turn is essential for the maintenance of plasticity-associated changes.
We therefor used Ca2+ imaging to monitor Ca2+ transients in stimulated neurons. Fluo-3 was used
to measure whole cell Ca2+ transients and GCaMP3nls, comprised of the genetically encoded Ca2+
indicator GCaMP3 [136] targeted to nucleus with an NLS peptide, was used to measure nuclear
Ca2+ changes. The same stimulation protocol as for arc gene analysis was used for Ca2+ imaging:
A B
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Figure 3.18: Bic stimulation for 10 seconds initiates arc transcription. (A) and (B) are Ca2+ imaging record-
ing in rat cultures infected with GCaMP3nls. Bic was put on cells for 10 sec or 2 min (colored
part between dotted lines in A and B, respectively) and then TTX was applied. (C) is the same
as (A) except that Fluo-3 was used to monitor Ca2+ change. (D) is quantitative analysis of
catFISH with arc gene. Percentage of arc positive cells in 10 sec and 10 min Bic stimulated
conditions are shown in green(16.08±1.338%) and red bars (31.35±2.555%, mean ± s.e.m.).
n= 6 independent culture preparations.
Bic was applied to cells and TTX was added after different time windows. As shown in Figure
3.18, Bic induced synchronized Ca2+ transients that decayed slowly over time and in which the first
transient had the largest amplitude (3.18 B). TTX efficiently blocked these Ca2+ rises immediately
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after its application (3.18 A and C). 10 sec Bic stimulation induced only one Ca2+ transient. These
findings indicate that very brief stimuli with a single nuclear Ca2+ transient is sufficient to initiate
arc gene transcription.
Chapter 4
Discussion
In this study, I used ChR2 as a tool to manipulate neuronal activity. A double mutant variant of
ChR2, ChR2-ab, was made, characterized and its cellular functions were studied. The goal was to
investigate whether intrinsic activity could be mimicked in a controllable way and if yes, how this
was achieved. The results indicated that ChR2-ab inherited the properties from its previous single
mutants, being more sensitive, longer opening and bi-stable. rAAV mediated expression of ChR2-
ab in neurons reached 80% in hippocampal culture. Endogenous activity could be mimicked with
ChR2-mediated, light-induced membrane depolarization. A pool of activity dependent genes (AID
genes) were induced in ChR2-ab-expressing neurons. The gene induction effect on AID genes
of ChR2-ab was L-type voltage-dependent Ca2+ channel dependent as it was completely blocked
with L-type VDCC antagonist nifedifine. Induction with atf3, ifi202b, inhba and serpinb2 was
inhibited with NMDA receptor blockers MK801 and APV. When synaptic activity was inhibited
with Na+ channel blocker TTX to prevent action potential firing, ChR2-ab-mediated induction of
atf3, inhba, npas4, nr4a1 and serpinb2 was also restrained. ChR2-ab-mediated gene induction
was nuclear Ca2+ dependent as when the function of nuclear Ca2+/CaM complex was impaired
with CaMBP4, gene induction was blocked. Interfering the function of CREB/CBP transcription
complex with E1A protein diminished gene expression induced with ChR2-ab. Whole-cell patch
clamp and signaling pathway analysis revealed that neurons expressing ChR2-ab showed higher
basal activity, represented with more frequent mEPSC and higher level of pCREB and pERK.
More cells died after light application in ChR2-ab-infected condition on DIV 14. Pharmacological
analysis suggested that this was due to activation of extra-synaptic NMDA receptors during ChR2-
ab activation. In another strategy of inducing activity, ChR2 was targeted to endoplasmic reticulum
membrane with various targeting sequences with the goal to directly introduce Ca2+ release from
internal Ca2+ stores. Additionally, transcription analysis with catFISH method revealed that a single
nuclear Ca2+ transient induced with Bic treatment was capable of initiating transcription of Arc
gene.
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4.1 ChR2 Mediated Activity and Gene Expression
4.1.1 Choosing the ChR2 Variant
When using ChR2s to manipulate neuronal activity, the ideal should be instantaneous and pre-
dictable membrane potential change. As mentioned in the Introduction 1.4.3, various ChR2 vari-
ants were used for divergent purposes [82]. ChR2-ab was chosen to be made for this study because
of its unique properties. ChR2-b has the most recently identified property of higher cation con-
ductance and increased sensitivity to light; ChR2-a has the mutation prolonging the opening of
the channel. ChR2-ab maintains blue light activation around 480 nm wavelength light and can be
de-activated with green light. Opening of the channels upon blue light is prolonged to minute scale
and cells expressing them were depolarized. This mimics the persistent neuronal activity effect of
KCl stimulation. Previous results showed that KCl mediated depolarization markedly increased
dendritic growth and branching [114, 150]. Membrane depolarization would induce a secondary
response, activating the L-type voltage dependent Ca2+ channels. Neuronal activity mediated with
high concentration of extracellular K+ was reported to be able to induce CREB/CBP-dependent
gene expression [60]. ChR2-ab mediated depolarization was reasoned to account for its function
in gene induction when stimulated with blue light. At the very beginning of this project, blue light
was applied through an optic fiber to each dish manually, trying to keep the stimulation the same for
all conditions. Later this was automated through a stimulator (S48 Square Pulse Stimulator, Grass
Technologies). To analyze the population effect in gene induction, blue light through a microscope
objective or a optic fiber is way from enough, so a customized LED plate had to be built up. Thanks
to the electronic workshop of Heidelberg University (Fachabteilung Elektronik), a LED array plate
with diameter of ∼13 cm was built for all the light mediated gene analysis experiments. The LED
units were from LUMITRONIX R© (Item No. 54401, 50 lm) which dominated at 467 nm with a
viewing angle of 100◦ . With rAAV infection, above 80% of the cell population expressed ChR2-ab.
With the LED array, cells in 35 mm diameter dish was all covered by blue light illumination.
There is another similar variant of ChR2, ChR2-ad (also called SSFO, Super Step Function
Opsin, obtained from SfN meeting, 2012) harboring mutants of C128A and D156A. This mu-
tant was shown to depolarize neurons more than ChR2-a, and probably less than ChR2-ab. Cells
expressing ChR2-ad did not show any mortality problem and was found to be able to enhance en-
dogenous firing upon light activation. If the cell death resulted from ChR2-ab was due to its over
depolarization in cell culture, ChR2-ad would be a better alternative for this purpose. However,
when we consider using this tool to generally increase activity in vivo, for example in Alzheimer’s
disease (AD) there is a significant loss of activity and neurons in cerebral cortex and certain sub-
cortical regions, due to the restrict transmission of blue light in brain tissue, ChR2-ab might be a
better choice. So the first thing to continue for ChR2-ab usage, I will stereotactic inject ChR2-ab
virus into hippocampus and check the cell survival situation. If cell death caused by ChR2-ab is not
the case in the brain, it will be used to increase circuit activity to rescue the cell loss in AD model.
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4.1.2 ChR2-ab Mediated Neuronal Activity and Its Function
Natural activity stimulation in vivo [53] and pharmacological induced synaptic activity in vitro
[157] have been shown to induce gene transcription. In this study, I used a controllable, exoge-
nous tool to induce and mimic neuronal activity. MEA recording revealed that blue LED light
induced bursts of spikes in ChR2-ab infected culture (Figure 4.4, data from Dr. H. Eckehard Fre-
itag). The light-dependent bursts stood out significantly from uninfected control cultures. This
activity achieved physiological function, activity-dependent gene induction. This gene induction
was observed only in ChR2-ab expressing cells but not in ChR2-a or ChR2-b infected cells (see
Figure 3.5). Considering the characteristics of these three ChR2 variants, depolarization mediated
by ChR2-a opening probably was not big enough to initiate gene responses. Gene analysis in this
thesis was all done at 4 hour time point, which is well established with Bic treatment in the lab
[156]. Previous data showed that 4 hour high KCl treatment induced expression of Dnmt3a2 [105]
which indicated that ChR2-a mediated depolarization did not reach the threshold to activate L-type
VDCC which started the downstream effects. ChR2-b itself mediated much bigger current and
much more sensitive to blue light, meaning less intensity of blue light would activate it. When
ChR2-ab was activated, the membrane depolarization was similar to that induced with KCl. And
this depolarization would last into time scale of minute. So the stimulation pattern used in gene
induction experiments was shed blue light every 30 second for a train of flashes (10 ms duration)
at 20 Hz for 6 seconds. This pattern was maintain from Micro-Electrode-Arrays (MEA) recording
of Bic stimulated neurons.
Apart from the 9 AID genes stated in the result part, 7 other genes were studied for their re-
sponses to ChR2-ab mediated activity. These were arc, bdnf, c-fos, dnmt3a1, dnmt3a2, egr1 and
puma. As shown in Figure 4.2 in Appendix, except for dnmt3a1 and puma, others were also robust
induced in ChR2-ab expressing neurons. Dnmt3a1 was not up regulated by Bic induced electrical
activity [105] and it was the same with ChR2-ab mediated activity in this work. Puma (also know
as bbc3) was shown to be down regulated with AP bursting activity [80] and it stayed unchanged
here. During performing the mRNA level analysis with Q-PCR protocol, I noticed that some genes,
including atf3, egr1, ifi202b and serpinb2 were significantly down regulated only by rAAV infec-
tion. This seems to be a common phenomenon in the lab and it may due to some side effects of the
virus infection itself. However, light treatment could induce robust expression of these genes.
Since virus did not infect all the cells in the population, we had infected and uninfected neu-
rons in the same dish.Evoked excitatory postsynaptic current (eEPSC) was recorded in uninfected
neurons in a ChR2 sparsely infected coverslips (unpublished data from Dr. C. Peter Bengtson).
This results indicate that synaptic transmission from ChR2 expressing neurons to downstream un-
infected cells indeed happen upon light activation. So the gene induction effect I observe probably
came from a direct response in ChR2-ab expressing neurons and a secondary response in postsy-
naptic neurons. To investigate the direct and secondary effect of ChR2-ab, I used a post-synaptic
density (PSD) targeting sequence to guide ChR2-ab to localize in the PSD (ChR2-ab-psd, [49]).
Immunocytochemistry with antibody against c-fos protein was used to detect its level in individual
neurons. When coverslips were analyzed as a unit, the one infected with ChR2-ab-psd and illu-
minated with blue LED light showed much higher level of c-fos staining (Figure 4.5 A). When I
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separately analyzed infected (mCh positive) and uninfected (mCh negative) cells in the same cov-
erslip, ChR2-ab-psd expressing neurons without light activation already showed higher c-fos level.
In the LED activated coverslip, ChR2-ab-psd positive neurons had remarkably increased level of
c-fos (Figure 4.5 B). Interestingly, uninfected neurons in the LED treated coverslip also had higher
intensity of c-fos staining compared to those in the un-illuminated coverslip. This indicated that
there was a secondary response at the network level in ChR2-ab-psd infected coverslip.
4.1.3 Restrictions on ChR2-ab Use
ChR2-ab did inherit the special properties from the single mutants: long opening, high sensitivity
and large ion conductance. All these characteristics also made ChR2-ab not suitable for precise
neuronal activity manipulation. When it was activated, cells expressing it would be depolarized for
up to a minute with slow decay. This depolarization could be reversed to with green light which
closed the channel immediately. Probably ambient light can already activate it. So the cells that
have ChR2-ab correctly expressed on cell membrane would be under sustained depolarization situ-
ation. This may account for the significant decrease in the inter event interval of mEPSC recording
(Figure 3.10 D) suggesting that under basal condition (without light activation), ChR2-ab is a bit
"leaky". This might be the reason for the high level of pERK and pCREB in ChR2-ab expressing
neurons (Figure 3.9). In fact, the higher basal pCREB level was also detected with ChR2-a ex-
pressing neurons, to a less extend. Light stimulation pulled it down. This was contrary to previous
report in which cells transduced with lentivirus carrying ChR2-EYFP had significantly elevated Ser
133 pCREB with blue light delivery compared with sham-treated neurons [49]. I checked whether
ambient light would cause channel activation by putting cells under the aluminium foil directly
after virus infection and keeping the tissue culture hood dark during medium change or other treat-
ments. But still, the high pCREB level was detected. Decrease of pCREB upon LED stimulation in
ChR2-ab expressing neurons was also out of our expect. Taking the bi-stable property (blue light
activate it and green light close it) of ChR2-ab into account, the ideal culturing condition would
be putting cells in a green light environment after infection, giving ChR2-ab no chance to be acti-
vated in any unintended way. In this case, ChR2-ab would be activated only when the blue light
is applied as designed. It can be achieved with a blue/green mixed LED array (with the help of a
two-output-channel stimulator) or two separate LED arrays used under different circumstances.
One explanation for high pCREB and pERK level in ChR2-ab expressing neurons without light
stimulation is that the leaky channel led to micro Ca2+ domain close to the cell membrane. Previous
work had shown that this was enough to switch on ERK signaling pathway. Once activated, ERK
pathway propagated in a Ca2+-independent way to the nucleus and resulted in CREB activation
[56]. However, in the case with ChR2-ab expressing neurons, any further treatments (LED light,
NMDA and KCl application) on those cells led to dramatic decrease on the high basal pCREB and
pERK level. In control uninfected cells, NMDA or KCl treatments would induce phosphorylation
of CREB and NMDA on top of KCl would de-phosphorylate CREB owing to activation of extrasy-
naptic NMDA receptors [62]. While in ChR2-ab infected cells, even KCl decreased the original
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high level of pCREB. The mechanism beneath still needs to be studied. Monitoring the Ca2+ con-
centration change would give us more information. Unfortunately, because of the sensitivity of
ChR2-ab to a broad spectra of light, Ca2+ imaging to recording the Ca2+ change in those infected
cells was not feasible. Fura-2 and X-rhod-1, which have excitation light (from LEDs which were
wavelength specific) far from blue light could still activate the channel, to variable extends.
Regarding the contribution of other receptors or channels in ChR2-ab mediated gene induction
effect, L-type VDCC was the most important one. Blockade of it prevented the gene induction
mediated by ChR2-ab. This was in agreement with our proposal that ChR2-ab activation causes
membrane depolarization which then activates L-type VDCC and downstream signaling pathways.
NMDA receptor blockade did not interfere the induction of btg2, gadd45β, gadd45γ, npas4 and
nr4a1 by ChR2-ab. And the induction of btg2, gadd45β, gadd45γ, npas4 and ifi202b was not
action potential dependent as preventing neuron firing by Na+ channel blocker TTX did not have
any effect on ChR2-ab mediated induction of these genes. This pharmacological analysis revealed
that ChR2-ab mediated gene induction generally required corporation from L-type VDCC, NMDA
receptor and Na+ channel.
The fact observed in this work that more cells died after blue light stimulation in ChR2-ab
infected condition indicated that these cells might have a failure in mitochondrial function because
of the channel expression. I tested this hypothesis by measuring the ATP level of uninfected and
ChR2-ab infected conditions with and without LED treatment. The results showed no difference
within condition with light stimulation. But there was a significantly decrease of ATP level in
infected condition (see Figure 4.3 in Appendix). This might due to the side effect of virus infection
as expression of the viral machinery took use of host cell energy to express exogenous proteins.
This effect became especially strong when cells were cultured longer than two weeks.
4.1.4 Conclusion and Outlook
Optogenetics has been broadly applied to various aspects of neuroscience research. Results from
this study presented a sign that ChRs can be deleterious. Many strategies have been used to in-
crease the expression level of ChRs in mammalian cells: mammalian codons substitution, stronger
promoter, ER exporting sequence to increase membrane insertion et al., but is the overwhelming
expression of a membrane protein good for cells, or can they bear it? More cells died over the
culturing process indicated that too many functional channels on the cell membrane might lead to
deleterious effect to cells.
Results from mEPSC recording provided a hint that ChR2-ab infected neurons had no differ-
ence in AMPA receptor number per synapse as the amplitude of mEPSC was similar to non-infected
cells. However, they might have more spines as they had more frequent mEPSCs. The morpho-
logical change of ChR2-ab infected neurons still needs to be studied. Gene induction mediated by
ChR2-ab indicates that it can be used as a cell depolarization tool to induce neuronal activity. Con-
sidering its super light sensitivity, in vivo application would be feasible and benefit substantially to
those suffering from decreased or lost neural network activity.
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4.2 ChR2 Targeting
Full length channelrhodopsin 2 has 737 residues and the N-term 315 amino acids were hypothe-
sized to be a 7-TM helices. When expressed in oocytes of X. laevis, in the presence of all-trans
retinal, identical photocurrent and very similar current-voltage relationships were obtained with the
full-length and the first 315aa ChR2s. This allowed for the conclusion that the N-term 7 TM helices
mediated the channel current [99]. So the topology of ChR2 was predicted to be 7 TM domain with
the N-terminal facing extracellular side and C- terminal in the intracellular side. It was confirmed
by crystal structure analysis of ChRs resolved at 2.3 Å resolution [73]. This high-resolution in-
formation revealed that ChR architecture to be very specific and different from many other known
transmembrane proteins. N-term in the extracellular side means that during he synthesis process,
there should be a stop-transfer anchor sequence and the N-term would stay inside the lumen of ER
before transferred on to plasma membrane. For the first try to guide ChR2 onto the inner nuclear
membrane (INM), I checked a typical INM locating protein, LBR. Lamin-B receptor (LBR) is a
polytopic integral membrane protein localized exclusively in the INM domain of the nuclear en-
velop. LBR has 8 TM locating on the INM and has its N-terminal in the intranuclear compartment
[104]. The first membrane spanning region of LBR was shown to be sufficient for sorting to the
INM [125]. At the same time, the amino-terminal domain of LBR was reported to be a nuclear
envelope targeting signal [126]. LBRN-GFP actually was shown to distribute equal and random
in ER and ONM but highly concentrated in the INM [38]. So I used the N-term and N-term plus
the first TM of LBR (LBRN-TM1) at the N-term of ChR2 and analyzed its distribution with high
resolution microscope. Unfortunately, both showed similar distribution pattern as the wild type
ChR2. Because integral proteins of the INM are synthesized as membrane-integrated proteins on
the peripheral ER, transport from ER to INM involved lateral diffusion in the lipid bilayer around
the nuclear pore membrane [101], I then turned to use ER retention sequences to target ChR2 onto
the ER membrane as the first step. As ER membrane system is in the continuality with outer nu-
clear membrane (ONM), it is possible that a ER membrane protein could accumulate in the nucleus
by lateral diffusion and designed ligand binding (nuclear trap strategy).
Many ER retention/retrievial signals were used (see Table 3.1) and the ones with arginine-
rich or lysine-rich motif (7aa-KLRRRRI and 6aa-FLKKYL) worked well. Targeted ChR2 showed
distinct distribution from plasma membrane bound one and it depicted the internal membrane sys-
tem. Ca2+ imaging recording revealed that no synchronized Ca2+ transients were induced with
ER targeted ChR2 according to light stimulation. Whole-cell patch clamp result represented that
the current mediated by ER-targeted ChR2 was greatly diminished compared to normal plasm
membrane-bound one. The small remaining current upon light stimulation might be accounted for
by a secondary effect of internal cation release from ER. Alternatively, it was conceivable that a
tiny fraction of ChR2 still inserted onto the cell membrane. In any case, these data indicated that
ER targeting of ChR2 was successful. However, the Ca2+ imaging result on the other hand was
disappointing because another purpose with ER targeted ChR2 was that I wanted to directly induce
Ca2+ release from ER. This result suggested that with wild type ChR2, which had little permeability
to Ca2+, it would not be suitable for this goal. As mentioned in Introduction 1.4.3, ChR2-c harbored
enhanced Ca2+ permeability and was shown to have superior properties [74]. So the immediate next
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step would be: to exchange ChR2-c for ChR2 in ER targeted constructs and check for Ca2+ release
from the ER.
4.3 Minimal Activity Requirement for Gene Transcription
New synthesized protein is crucial for sustained neuronal functional change and formation of long-
term memories. So we set off to investigate the minimal activity requirement for gene transcription
initiation. The very original idea was to use ChR2-b as the controllable activity tool to explore this
question. ChR2-b can be activated with as low as 1.9 mW/mm2 light intensity and as high as 60 Hz
blue flashes to produce reliable action potentials [12]. But no gene transcription was detected even
with high frequency flashes in ChR2-b infected neurons. In contrast, Bic induced bursts of action
potentials, although with lower firing frequency, induced robust gene transcription. This suggested
that it may not be the frequency or number of action potentials leading to the transcription. Down-
stream effectors, possibly Ca2+ signals which invade into the nuclei, are still needed to be explored.
As mentioned above, fine Ca2+ imaging with ChR2 is still a problem, especially with ChR2-b. In
this sense, ChR2-b is a bit too sensitive as it can be activated with most other wavelength of Ca2+
imaging lights.
I chose arc as the model gene because its expression is tightly activity regulated and it plays very
important role in activity mediated learning and memory [122]. Arc is one of the few immediate
early genes which get transcribed at the very early state. It was massively induced 5 min after
the rat being put into a novel environment [142]. Arc transcripts first stay in the nuclei as very
concentrated foci and then translocated into cytosol and dendrites. In this body of work, I made
use of the first stage of activity regulated arc transcription. A very sensitive method, catFISH, was
used to detect arc transcripts at the mRNA level. Ten minutes Bic stimulation point was chosen for
most of the experiments because it gave the best intranuclear foci signal. But during the progress
of this study, some technique problem came up: arc signal became blur and not concentrated;
counter staining of nucleus with Hoechst also lost its structure and had fuzzy boundary. Many
control experiments were planned and executed and the hybridization solution at 56◦C was found
to be the cause of it. The pH of hybridization buffer dropped massively when it is heated up to
56 ◦C in a formamide humidified chamber while it stayed around pH7 when it was kept in a closed
eppentube. The acid environment came from the oxygenation of formamide at high temperature
and oxygen rich atmosphere. It was the acid solution stripped the nuclear structure and led to the
blurring detecting results.
The results showed that a single nuclear Ca2+ transient, within 10 seconds, was sufficient to ini-
tiate arc gene transcription. But it took longer for it to be detected. This matches with the working
mechanism of the molecular transcription machinery. Transcription initiation needs polymerase II
(Pol II), general transcription factors (TFIIA, TFIIB, etc.), gene specific transcription factors (e.g.
CREB) and co-factors (e.g. CBP). Once Pol II starts transcribing from the template DNA, this pro-
cess is not activity dependent. But it takes time for those already-started transcripts to be finished.
That is probably why in Figure 3.17 A (Bic-2’ and Bic-5’), when cell were fixed immediately after
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2 or 5 min Bic stimulation, no significant arc transcript signals were detected in any cell. However,
if cells were given some time to finish the already-started transcription (Bic-2’+8’ and Bic-5’+5’),
about 15% cells showed arc mRNA signals. The percentage of arc positive cells was comparable to
that of continuous 10 min Bic stimulation. Results from this study add to the fact that arc is one of
the very first transcribed IEGs and its transcription initiation requires minimal one Ca2+ transient.
Percent of Arc positive cells increased along with the stimulation periods and it reached 72% of the
population after one hour. This accumulative result suggests that some cells in the culture are more
sensitive than the others to activity change and respond immediately.
Detection of the first arc transcripts to some extend relied on the very low basal activity during
the culturing and handling. To minimize the basal activity of the culture, I used rat hippocam-
pal neurons cultured in a L-15 medium (Leibovitz) based growth medium (no Glutamine L-15
75.85%, NaHCO3 0.2%, SVM 0.45%, Progesterone 1mM, 112 2.4%, ITS 0.5%, Putrescine 1.6
mg/ml, Transferring 5 mg/ml, rat serum 1%, B27 2%). According to the experience and recording
from MEA, rat cells in this medium show much less spontaneous activities. And in this set of
experiments, no arc in situ hybridization signal was detected in control untreated condition.
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Figure 4.1: ChR2-b is activated by a broad spectra of lights. (A) is the overview of the responses of ChR2-b
illuminated with Fura-2 excitation lights (340/30 nm and 380/10 nm) and normal channel acti-
vation light (450/30nm). Note that in voltage clamp, both 450/30 nm and 380/10nm caused a
breakthrough of the cells, represented by the huge sharp inward current. (B) is a zoomed-in im-
age showing the currents mediated by channel. Basically, both excitation light of Fura-2 could
activate ChR2-b, just to different extends. This is also true for X-rhod-1 excitation light.
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Figure 4.2: Summary of gene induction effect on 16 genes by ChR2-ab-mCh mediated activity. Q-PCR
analysis of relative gene expression of total 16 genes analyzed in this study of cells infected
with virus carrying ChR2-ab-mCh construct after 4 hour blue LED light stimulation (n ≥ 12
independent cell preparations). Dotted line represents 1, which means those genes were not
induced.
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Figure 4.3: No change in ATP production with and without light in ChR2-ab expressing cells. Cells were
infected with ChR2-ab-mCh (ab) or ChR2-be-mCh (be, as a channel control) or not infected
(no inf.). On DIV 14, TM was changed to CO2-independent SGG (140.1 mM NaCl, 5.3 mM
KCl, 1 mM MgCl2, 2 mM CaCl2, 10 mM HEPES, 1 mM glycine, 30 mM glucose and 0.5
mM sodium pyruvate) prior to experiment. After 4 hour blue LED light stimulation, cells were
lysated and applied to ATP detection assay "ATPlite 1step Luminescence ATP Detection Assay
System" (PerkinElmer R©) according to the manufacturer’s instructions (n = 2 independent cell
preparations). The measurement was performed at room temperature. ATP level was normal-
ized to control condition without LED treatment. No difference was detected within the same
infection group with or without LED; but a significate decrease of ATP level was noted between
the uninfected and infected groups.
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Figure 4.4: Bursts of spikes induced with blue light in ChR2-ab infected multi-electrode array (MEA) cul-
ture. Rat hippocampal neurons were cultured on MEA and recording was performed on DIV
10. As shown in (A), cells were illuminated every minute for 1 second with a fiber optic guided
light from a blue LED. The blue line represents the first LED stimulation. Following blue dots
above the graph indicate the 1 s light on every 60 seconds. The relative number of spikes was
plotted against time. ChR2-ab infected culture (solid circle) responded robustly to light stimu-
lation compared to uninfected condition (hollow circle). Time scale was adjusted to have light
flash positioned at 0 point. Data from Dr. H Eckehard Freitag.
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Figure 4.5: Blue light stimulation induced expression of c-fos in both infection positive and negative neu-
rons in ChR2-ab-psd infected culture. (A) shows immunocytochemistry (ICC) analysis of c-fos
protein level in uninfected and ChR2-ab infected groups with and without LED treatment. C-fos
level is represented with the staining intensity in arbitrary unit (a.u.). C-fos increase was de-
tected only in the infected condition with light stimulation. (B) represents c-fos level only from
ChR2-ab infected conditions, with (LED) or without (Control) light treatment. Uninfected (mCh
negative, blank bars) and ChR2-ab infected (mCh positive, red bars) cells in the same coverslip
were analyzed separately. ChR2-ab expressing cells without light treatment already have higher
level of c-fos staining and this was robustly induced with blue light stimulation. ChR2-ab neg-
ative cells in the LED treated condition also show significant higher level compared to those in
un-illuminated condition.
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